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Abstract 
Glaucoma is a general term that includes an array of ocular conditions that cause a 
specific neuropathy of the optic nerve (Greenfield, Bagga, et al. 2003) of which 
abnormalities associated with this disorder are localized at the level of the retinal 
ganglion cell layer (Epstein 1997; Quigley & Broman 2006).  This structure-function 
relationship is not clear as it relies on several factors such as variability from the 
structural and functional tests, differences in measurement scales between the two 
modalities (Greaney et al. 2002; Katz 1999; Drance 1985; Hood et al. 2007) and 
physiological variation amongst individuals (Pan & Swanson 2006). 
 
The global aim of this thesis was to relate visual function of the retinal ganglion cells to 
structure of the optic nerve head and retinal nerve fiber layer with respect to the 
following perimetry techniques: i) standard automated perimetry (SAP), ii) frequency 
doubling technology (FDT), iii) flicker defined form (FDF), and iv) the motion detection 
test (MDT), and the following imaging instruments: i) confocal scanning laser 
ophthalmoscopy (HRT), ii) optical coherence tomography (OCT), and iii) scanning laser 
polarimetry (GDx VCC).   
 
The specific purpose of this study was to i) compare the test-retest characteristics of the 
perimetry techniques, ii) determine which may be more sensitive for early detection, iii) 
evaluate the structure-function relationship between measures of retinal nerve fiber 
layer and visual function, and iv) perform a preliminary study to determine which 
 iv 
techniques may be most suitable to monitor progression, in patients with early stage 
glaucoma.  
 
MDT showed little change in the 1-year follow-up study thus being unsuitable for 
monitoring change.  FDT and FDF gave a similar performance and are likely optimal for 
the detection of early functional damage.  
 
Poor diagnostic agreement was seen between the HRT and each perimetry technique.  
Because no one perimetry test showed both high sensitivity and high specificity, it is 
recommended that a combination of FDF with either SAP, FDT or MDT be used as the 
functional component in the diagnosis and follow-up of patients with glaucoma.   
 
The strongest global structure-function correlations for OCT were seen with SAP, FDT 
and MDT; for GDx, the strongest association was seen with FDF.  These results 
suggest that FDF and GDx used in combination are best to detect early glaucomatous 
changes.  
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VCC  variable corneal compensation 
VF  visual field 
VFI  visual field index 
vs  versus 
WEBS weighted binary search 
WNL  within normal limits 
WW  white-on-white perimetry 
ZEST  zippy estimation of sequential testing 
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1. Introduction 
 
1.1 Glaucoma 
 
Glaucoma is a general term that includes an array of ocular conditions that cause a 
specific neuropathy of the optic nerve (Gupta & Chen 2016) of which abnormalities 
associated with this disorder are localized at the level of the retinal ganglion cell layer 
(Epstein 1997; Quigley & Broman 2006).  The early stage of glaucoma is a very gradual 
process; depressions of sensitivity noted in the patients’ visual field often appear and 
disappear before becoming stable defects (Heijl & Patella 2002).  Once stabilized, these 
defects, referred to as scotomas, begin to enlarge and pursue the arcuate pattern of the 
retinal nerve fibers.  In the later stages, large scotomas from the superior and inferior 
field reach into the peripheral field and connect leaving only the central or temporal 
visual field intact (Weber et al. 1989; Quigley et al. 1989).  Many times, the patients will 
not be able to detect any loss of vision until the later stages as a relative loss in 
sensitivity is difficult to be detected by the patient even with a relatively large scotoma. 
 
The loss of retinal ganglion cells (RGC) and their axons is the essential pathological 
process in this disease (Quigley et al. 1989; Johnson 2009).  Histopathologic studies of 
both human and animal eyes have shown that the primary site for glaucoma damage is 
the RGC axons at the lamina cribrosa (Burgoyne 2011; Quigley & Anderson 1976; 
Quigley et al. 1981; Minckler et al. 1977; Guedes et al. 2003).  Progressive 
 2 
glaucomatous loss of RGC causes characteristic optic nerve, retinal nerve fiber layer 
(RNFL) and visual field abnormalities (Epstein 1997; Johnson 2009; Nicolela et al. 2001; 
Quigley 1993).  The RNFL is composed of retinal ganglion cells, neuroglia and 
astrocytes (Epstein 1997).  
 
In glaucoma, RGCs have been shown to die by apoptosis after going through 
morphologic changes of dendritic field size reduction, axon atrophy and soma shrinkage 
(Almasieh et al. 2012; Quigley et al. 1995; Garcia-Valenzuela et al. 1995).  This gradual 
morphogenesis leading to apoptosis leads some to believe that this time can allow for 
neuroprotective intervention and hence salvage the RGCs (Kwon et al. 2009).  This 
stresses the importance and need for instruments which detect glaucoma early in the 
disease.   
 
1.2 Primary Open Angle Glaucoma 
 
Primary Open Angle Glaucoma (POAG) is the most common form of glaucoma 
(Allingham et al. 2005) and is characteristic of an open iridocorneal angle in which 
aqueous humor (AH) outflow is diminished and cupping of the optic nerve head (ONH) 
occurs with corresponding loss of visual field (Kwon et al. 2009; Allingham et al. 2005) 
in the characteristic pattern described above. 
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1.3 Structure in Glaucoma 
 
Destruction of nerve fibers results in loss of normal NFL architecture therefore, 
evaluation of RNFL thickness is important for the early detection of glaucoma (Quigley 
et al. 1994; Lim et al. 2016, Fingeret et al., 2005; Kotowski et al., 2014; Quigley et al., 
1992). A review by Greenfield and Weinreb (2008) have highlighted the importance of 
optic nerve head documentation in monitoring glaucoma.   
Optic nerve topography is dependent upon the number, size and orientation of nerve 
fiber axons entering it from the retina (Jonas et al. 1992).  Both age (Mikelberg et al. 
1989; Repka & Quigley 1989; Balazsi et al. 1984; Poinoosawmy et al. 1997; Quigley et 
al. 1991) and ONH size (Mikelberg et al. 1989; Chen et al. 2009) determine the number 
of ganglion cells and nerve fibers present.  
Several patterns of glaucomatous optic disc and nerve fiber layer damage have been 
described (Airaksinen et al. 1984; Drance et al. 1986; Caprioli et al. 1987; Jonas et al. 
1988; Caprioli 1989; Tuulonen & Airaksinen 1991; King et al. 2000).  Structural changes 
in glaucoma include enlargement of the optic cup size (Minckler et al. 1977; Airaksinen 
et al. 1984; Airaksinen & Heijl 1983; Zeyen & Caprioli 1993; Drance et al. 1977), 
morphological changes to the lamina cribrosa (Burgoyne 2004; Morgan-Davies et al. 
2004; Faridi et al. 2014), large or asymmetric cup-to-disc (C/D) ratios and changes over 
time (Quigley et al. 1994), disc hemorrhages (Quigley et al. 1994; Airaksinen & 
Tuulonen 1984; Diehl et al. 1990; Bengtsson 1990; Sommer et al. 1991), NFL 
abnormalities (TG & Caprioli 1993; Quigley et al. 1992; Tuulonen et al. 1993; Chandra 
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et al. 2013; GDx VCC Primer 2004), damage (Johnson 2009) and decrease in the 
number of optic nerve head fibers (Harwerth et al. 1999), rim thinning, notching and 
excavation (Quigley et al. 1994; AW & Bailey 1993).  Loss of neuroretinal rim and 
increase in optic cupping are parallel with the loss of optic nerve axons in glaucoma 
(Teal et al. 1972; Airaksinen & Drance 1985).   
 
Clinically, distinguishing between normal and glaucomatous optic nerve is a challenge.  
The difficulty in detecting early to moderate ONH damage is for the most part due to the 
large variability of the ONH size and appearance in normal individuals (Jonas et al. 
1988; Bengtsson 1976); rim area and cup size vary significantly due to variation in disc 
size (Jonas et al. 1988; Bengtsson 1976; Quigley et al. 1990) and ethnic origin 
(Beck et al. 1985; Chi et al. 1989; Varma et al. 1994; J 1971).  There also exists a large 
variability between glaucoma experts in evaluating the optic disc for glaucoma diagnosis 
or signs of progression (Lichter 1976; Pederson & Anderson 1980; Zeyen et al. 2003; 
Tanna et al. 2011).  Thus, a more objective method of ONH and RNFL documentation is 
needed. 
 
The two main applications for optic nerve head analysis in the diagnosis and treatment 
for glaucoma are i) distinguishing between normal and disease of optic nerve heads and 
ii) identifying progression with successive tests (Fingeret, Medeiros, et al. 2005).  Both 
accurate and reproducible measurements are essential for early diagnosis and 
detection of progression (Fingeret, Medeiros, et al. 2005).   
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Various imaging techniques available for recording the structure of the optic nerve head 
and retina use different properties of light and are aimed at detecting different 
characteristics of retinal tissue in order to quantitatively assess topography and other 
structural properties of the ONH and RNFL (Ventura et al. 2006; Weinreb 1999; 
Weinreb et al. 1990; Weinreb et al. 1993; Huang et al. 1991; Hoh et al. 2000; Greenfield 
2002; Kotera et al. 2008; Zangwill et al. 2000; Niessen et al. 1996; Chang & Budenz 
2008).  Such techniques include, optical coherence tomography (OCT) (Schuman, Hee, 
Arya, et al. 1995; Schuman et al. 1996; Strouthidis & Garway-Heath 2008), confocal 
scanning laser ophthalmoscopy (CSLO) (Fechtner et al. 1993; Uchida et al. 1996; 
Zangwill et al. 1996; Lemij & Reus 2008), and scanning laser polarimetry (SLP) (Zeimer 
et al. 1998). These techniques can provide precise and objective quantitative 
measurements of the RNFL and ONH (Wollstein et al. 1998; Swanson et al. 1993; Teal 
et al. 1972; Hoh et al. 2000; Drexler et al. 1999; Weinreb, Shakiba & Zangwill 1995; 
Weinreb, Shakiba, Sample, et al. 1995) which can help with the diagnosis and 
monitoring of diseases that affect the optic nerve (Samarawickrama et al. 2012) and 
have been shown to discriminate between normal, OHT, POAG, and NTG subjects 
(Zangwill et al. 1996; Anton et al. 2007).  Both hardware and software upgrades have 
been applied to all these instruments since their earlier versions which have allowed for 
more sensitive detection and monitoring of glaucoma (Fechtner & Lama 1999).  Patients 
were more accurately screened for early perimetric glaucoma when parameters from 
more than one instrument were combined (Greaney et al. 2002).  
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In early glaucoma, structural damage is more readily detectable in larger optic discs 
(Quigley et al., 1982; Zangwill et al., 2000).  Both clinical and experimental observations 
of the peripapillary NFL region have shown that the earliest signs of NFL damage as a 
result of glaucoma are along the superiotemporal and inferiotemporal bundles (Leung et 
al., 2010).  In normal adults, the neuroretinal rim width is greatest inferiorly, then 
superiorly, nasally then temporally (Quigley et al. 1990) resulting in a horizontally oval 
cup shape.  Any changes to this configuration can be due to glaucoma hence, 
identifying the neuroretinal rim width is key in the diagnosis and monitoring of glaucoma 
(Hoyt & Newman 1972). 
 
Measuring macular thickness is becoming a useful tool in detecting early glaucomatous 
damage as it is highly dense with RGCs (Aref 2013; Zeimer et al. 1998; Greenfield, 
Bagga, et al. 2003).  A recent study suggests using a perimetry technique with a more 
dense test grid pattern in the macular region to detect macular damage caused by 
glaucoma (Grillo et al. 2016).    
 
1.4 Function in Glaucoma 
 
One of the most common measures of visual function is static automated perimetry 
(Garway-Heath et al. 2002; Flammer et al. 1985) which measure the extent and depth of 
visual field damage by determining the eye’s ability to detect small points of light 
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projected onto both the central and peripheral areas of the field of vision.  The purpose 
of a visual field examination in glaucoma is to detect defects and determine the specific 
pattern of visual field loss for diagnostic purposes, and monitor patients for evidence of 
visual function deficit progression (Chauhan et al. 1990; Spry et al. 2001; Spry & 
Johnson 2002).   
 
The use of automated perimeters has allowed for detection of relative scotomas within 
the visual field.  The neural-sensitivity hypothesis states that the proportion of RGC loss 
determines perimetry thresholds (Tate 1985; Frisén 1993; Bartz-Schmidt & Weber 1993; 
Harwerth et al. 2004; Kerrigan-Baumrind et al. 2000; Harwerth et al. 2007; Harwerth & 
Quigley 2010; Garway-Heath et al. 2002; AGIS Investigators 1994) therefore, through 
psychophysical testing, the ocular effects of glaucoma can be quantified (Katz 1999) 
giving a functional correlate to the damage. 
 
Evaluating a patient’s glaucoma status based on his or her visual field results requires 
statistical analysis to determine how the results differ from expected values and how it is 
related to the RGCs and helps estimate glaucoma severity (AGIS Investigators 1994).  
This thesis will be comparing different perimetry techniques to determine the ability of 
each at detecting functional changes due to glaucoma and determine which may be 
more suitable for early detection.   
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1.6 Structure and Function in Glaucoma 
 
Defining the relationship between structural and functional loss in glaucoma has been of 
great interest since the 1850s (Drance 1974).  Von Graefe, Jaeger, Weber and 
Mackenzie were among the group who founded the relationship between the 
appearance of the optic nerve and glaucomatous visual field defects (Duke-Elder 1941).  
The relationship between structure and function of the retinal ganglion cells is not very 
accurate (Harwerth et al. 2007; Harwerth & Quigley 2006; Harwerth et al. 2002; 
Johnson et al. 2000) as it relies on several factors such as variability from the structural 
and functional tests, differences in measurement scales between the two modalities 
(Garway-Heath et al. 2002; Katz 1999; Drance 1985; Hood & Kardon 2007), spatial 
summation (Drance 1985; Hood & Kardon 2007; Budenz et al. 2002; Pan & Swanson 
2006) and physiological variation amongst individuals (Pan & Swanson 2006).   
 
Correlation between structural and functional changes in glaucoma can be seen in less 
than 50% of glaucoma cases, even with the use of advanced diagnostic and analytic 
procedures (Drance 1985; Turpin et al. 2009; Gardiner et al. 2005; Garway-Heath, 
Caprioli, et al. 2000; Strouthidis, Vinciotti, et al. 2006).  Many studies have shown that 
structural changes can be observed before any functional change is detected (Johnson 
2009; Harwerth et al. 1999; Drance et al. 1977; Quigley et al. 1992; WC 1990; Johnson 
1994; Breton & B 1989; Chauhan et al. 2001; Aptel et al. 2010; Sung et al. 2011; 
Harwerth 2008) i.e. thinning of the RNFL or neuroretinal rim is often seen in patients 
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with normal standard automated perimetry measures (Sung et al. 2011; Airaksinen & 
Heijl 1983; Airaksinen & Drance 1985; Lan et al. 2003), while other studies have shown 
either parameter can change before the other or simultaneously (Kass et al. 2002; Heijl 
et al. 2002; Malik et al. 2012a).   
 
In patients with glaucoma, the observed patterns of visual field abnormalities 
correspond to the anatomy of the RNFL and its projections to the ONH (Breton & Drum 
1989; Choplin 2007).  Initial studies were conducted by Quigley who demonstrated that 
40% axonal loss may occur before any noticeable changes in visual function (Quigley et 
al. 1982).  Further studies showed that 20% to 50% of retinal ganglion cell loss is 
required to first detect any significant visual function defect and that this value varies 
with retinal eccentricity (Quigley et al. 1982; Harwerth et al. 2007).     
Strong evidence suggests that glaucoma can progress to a moderate a stage before a 
visual field defect is seen on SAP (Johnson 2009; Harwerth et al. 1999; Zeyen & 
Caprioli 1993; Quigley et al. 1992; Tuulonen et al. 1993; Chandra et al. 2013; Hart et al. 
1978; Sommer et al. 1979a) and structural changes are present before any visual field 
damage is detected by SAP (Kuang et al. 2015; Quigley et al. 1992; Chandra et al. 
2013; Wilensky & Kolker 1976; Leung et al. 2005; Kanamori et al. 2008; Reus et al. 
2006; Bowd et al. 2006a).  Recent studies have reported less RGC loss with SAP 
(Fechtner & Lama 1999; Ventura et al. 2006; Park et al. 2011; Jung et al. 2012).  Thus, 
techniques that are more sensitive to measuring RNFL are needed to help with the 
accurate diagnosis and monitoring of glaucoma (Medeiros & Weinreb 2002).   
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The OHTS (Keltner et al. 2006) and the European Glaucoma Prevention Study (Miglior 
2005) have found that initial glaucomatous damage can be either structural, functional 
or both.  Factors such as age (Honjo et al. 2015; Zueva et al. 2016) and the presence of 
initial functional changes (Öhnell et al. 2016) can influence the diagnostic capabilities of 
each parameter.  Measurement of structural changes to the ONH and RNFL offers the 
prospect of improved early detection and monitoring of glaucoma (Quigley 1986; Drance 
1985; Bowd et al. 2001).  Therefore, it is imperative to use both structural and functional 
measurements comprehensively to make clinical decisions regarding the disease 
(Garway-Heath 2007; Airaksinen et al. 1985; Airaksinen & Drance 1985). 
 
It should also be noted that dissociation between structural and functional 
measurements occur, such that some structural changes are not associated with loss of 
RGCs and functional changes are not related to cell loss but cell dysfunction (Garway-
Heath 2007).  Cell shrinkage and methods used to determine number of ganglion cells 
could affect retinal ganglion cell count (Airaksinen & Alanko 1983).  Different types of 
perimetric techniques require loss of varying numbers of ganglion cells to show different 
depths of visual field defect (Johnson 1994; AGIS Investigators 1994) explaining the 
discrepancy seen amongst perimetry techniques in detecting glaucomatous changes.   
 
Harwerth et al (2005) have described that the structure-function relationship is different 
at different stages of the disease. This relationship has been proposed to be curvilinear 
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when plotted in linear/logarithmic units (Hood et al. 2007).  Hence, functional changes 
are smaller per unit structure in the early stages than later in the course of the disease 
(Artes 2008).  Thus, it has been proposed that early stages of glaucoma should be 
monitored with structural measurements and later stages should be followed with 
functional tests.   
 
Studies have shown that structural damage does not occur without functional 
consequences (Harwerth & Quigley 2006; Kanamori et al. 2006) and both structure and 
function test should be used together to help with the follow up of patients with 
glaucoma (Artes & Chauhan 2005a; Strouthidis, Vinciotti, et al. 2006).  Recent studies 
confirm the hypothesis that the structure-function relationship changes with age (Ren et 
al. 2014; Honjo et al. 2015). 
 
The RGC redundancy hypothesis (also known as, RGC functional reserve hypothesis) 
presents a theory regarding the structure-function relationship in early glaucoma 
(Ventura et al. 2006).  It proposes that as much >25% of RGCs and their axons can be 
lost (Kerrigan-Baumrind et al. 2000; Quigley et al. 1992) before SAP detects loss in 
visual function (Ventura et al. 2006), i.e significant retinal thinning can occur but not be 
corroborated by visual field testing (Medeiros et al. 2004; Asrani et al. 2003).   
Studies in monkeys with experimental glaucoma have reported a progressive functional 
loss in SAP with increasing loss of RGCs above 50% (Harwerth et al. 2002).  However, 
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in some areas of the retina, sensitivity losses of 6-12dB were seen on SAP with 0-10% 
RGC loss (Harwerth et al. 2002).   
 
The impression of a functional-reserve hypothesis is due to the difference in scaling 
between structural (percentage) and functional (decibel, dB) measurements (Garway-
Heath et al. 2002; Reus & Lemij 2004b; Garway-Heath, Caprioli, et al. 2000); because 
visual function is measured on a dB (nonlinear) scale, structural changes occur at a 
faster rate than VF changes in the early stages and this relation is reversed in the later 
stages (Airaksinen & Drance 1985).   
 
Neural density (measured in %-age loss) and visual sensitivity (measured by dB) have a 
curvilinear relationship (Garway-Heath et al. 2002; Airaksinen & Drance 1985; Bartz-
Schmidt et al. 1999; Jonas & Grundler 1997).  A logarithmic transformation of either 
variable produces a linear relationship for prediction of structural loss from functional 
measurements (Harwerth et al. 2004). However, the accuracy of this model is best 
suited for moderate to advanced glaucomatous neuropathy during which subjective 
perimetric measurements are more accurate than objective structural measurements 
(Sommer et al. 1991; Drance 1975; Sanchez-Galeana et al. 2001; Johnson et al. 2003; 
Matsumoto et al. 2003).  Hence automated perimetry is likely to remain the gold 
standard for assessment of stage of neural damage from glaucoma (Johnson 1996).  
Because structural changes of the RNFL and ONH often precede development of visual 
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field loss in glaucoma (Repka & Quigley 1989; Kerrigan-Baumrind et al. 2000), the 
detection of damage to RNFL and ONH is critical for the early diagnosis of glaucoma. 
 
Several studies have suggested that decreasing IOP can reverse RGC dysfunction 
(Ventura & Porciatti 2005; Gandolfi et al. 2005).  Looking at these studies together gives 
rise to the “dysfunction-preceding-death hypothesis” (Ventura et al. 2006).  In RGC 
losses of less than 50%, there are only small changes (in decibels) of visual loss, 
whereas in RGC losses greater than 50%, the visual sensitivity is more closely 
correlated (Garway-Heath et al. 2002).  This may arise because visual sensitivity loss is 
measured in dB whereas RGC loss is measured in percentage.  If both variables were 
measured with a linear scale, a linear relationship may be noted between RGC and 
visual sensitivity loss regardless of the stage of glaucoma (Garway-Heath et al. 2002; 
Swanson et al. 2004; Schlottmann et al. 2004).  
The development of more objective, quantitative methods of combining structural and 
functional information has been of interest to several investigative groups (Harwerth et 
al. 2007; Drance 1985; Strouthidis, Vinciotti, et al. 2006; Turpin et al. 2009; Mardin et al. 
2006; Ronald S. Harwerth et al. 2005).  This thesis will investigate the structure function 
relationship amongst several perimetry techniques and imaging modalities to determine 
which pair of instruments shows the strongest correlation. 
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1.6 Standard Automated Perimetry:  Humphrey Field Analyzer 
1.6.1 HFA:  Instrument Specifications 
Standard Automated Perimetry (SAP), also known as white-on white perimetry, is 
currently the gold standard for detecting glaucomatous visual field loss (Nicolela et al. 
2001; Quigley 1993; Sommer et al. 1991; Johnson 1996; Bayer & Erb 2002; Anderson 
1987; Alexander 1991; Johnson & Sample 2003; Sekhar et al. 2000).  The Humphrey 
Field Analyzer (HFA; Carl Zeiss Meditec, Dublin, CA, USA) uses differential light 
sensitivity to measure the eye’s ability to detect small flashes of white light (usually 0.43˚ 
diameter, Goldmann size III) on a background luminance of 10 cd/m2 or 31.5 asb. The 
Goldmann size III stimulus is most commonly used as it provides a valid assessment of 
neural loss (Harwerth et al. 2002) and the specific background illumination was chosen 
as it is the minimum amount of light needed to stimulate both cone and rod 
photoreceptors (Heijl & Patella 2002).  
 
The 24-2 stimulus pattern available on the HFA tests 54 points within the central 24 
degrees of the field of vision with an extension of 30 degrees in the nasal region; each 
test location is separated by 6˚ and offset by 3˚ from both the horizontal and vertical 
meridians (Zalta 1991).  The HFA is installed with a statistical software package, 
STATPAC, which provides a rapid analysis of the patient’s visual field along with a 
comparison of the patient’s sensitivity values with that of an age-matched normal 
population (Heijl & Patella 2002).  
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1.6.2 HFA:  Bracketing Strategy 
 
The standard algorithm of the HFA uses a bracketing strategy, a 4-2-2 dB staircase, to 
estimate threshold levels (Walsh 1990).  Depending on the patient’s response to the 
initial stimulus presented at each location, the proceeding stimulus intensity will increase 
or decrease (Delgado et al. 2002) by 4 dB.  When the patient’s response pattern 
changes at a given test location, the intensity will be altered by a smaller interval of 2 
dB; this reversal is repeated several times until consistent responses are obtained and 
the threshold is determined.  The threshold expresses the intensity of light that the 
patient can see 50% of the time the stimulus is presented at the specified retinal 
location. 
 
1.6.3 HFA:  SITA  
 
The Swedish Interactive Test Algorithm (SITA) is a family of test algorithms designed to 
reduce threshold estimation test time for the stimulus patterns available on HFA without 
compromising the data quality (Sekhar et al. 2000; Bengtsson et al. 1998; Wild et al. 
1999).  Studies have shown that lengthier tests result in lower threshold estimates as a 
result of fatigue (Wild et al. 1999; Heijl et al. 2000; Bengtsson, Olsson, et al. 1997).  The 
SITA algorithms use maximum likelihood methods to estimate threshold values 
(Bengtsson, Olsson, et al. 1997).   
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Unlike the full threshold (4-2-2 dB staircase) techniques where each test location 
presents a stimulus with a specified intensity, SITA calculates the initial intensity for test 
locations based on the known relationship of location sensitivity in the normal visual field 
(Bengtsson, Olsson, et al. 1997).  SITA has allowed perimetry testing to be more 
reliable and accurate with significantly shorter test duration (Sekhar et al. 2000).  A 
study by Artes et al. (2002) has shown that SITA Standard may be superior to the Full 
Threshold algorithm when measuring patients with visual field loss; this could be 
attributed to less fatigue experienced by the patient during the test.  
 
 
1.7 Function Specific Perimetry 
 
As stated previously, studies have shown that RNFL and ONH changes can be detected 
before changes to the visual field as noted by standard automated perimetry (Harwerth 
et al. 1999; Kerrigan-Baumrind et al. 2000; Johnson 1994; Sommer et al. 1991; Ronald 
S. Harwerth et al. 2005; Lan et al. 2003; Johnson et al. 2003; Okubo 1986).  The 
emergence of new functional tests that are more sensitive than SAP lead to the 
possibility that functional loss may occur with, or even before, structural loss (Airaksinen 
& Alanko 1983; Fortune et al. 2012). 
 
The development of new perimetry techniques has been aimed at selectively testing 
subsets of ganglion cells to better reflect ganglion cell loss (selective testing hypothesis) 
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(Johnson 1994), or testing subsets of ganglion cells that may be more prone to 
glaucomatous damage (selective loss hypothesis) (Alward 2000), or testing higher order 
cognitive functions that appear to be more prone to early disease. 
 
It has been shown that SAP with Goldmann size III stimulus provides a more accurate 
assessment of advanced RGC loss than mild RGC loss especially in threshold losses 
greater than 15 dB, in excess of 50% RGC loss (AGIS Investigators 1994; Hart et al. 
1990).  This promotes Johnson’s Reduced Redundancy Hypothesis (Johnson 1994) 
which states that early functional loss can be detected if testing for a select 
subpopulation of ganglion cells which are preferably damaged earlier in the disease 
stage (Stewart 1990) or have a sparse distribution throughout the retina (Johnson 
1994).  This testing approach may be more suitable in detecting change earlier than 
using a stimulus with the potential of stimulating a subset of ganglion cells.  
 
Whether or not glaucoma affects retinal ganglion cells preferentially (Alward 2000; 
Quigley et al. 1988) or non-preferentially (Johnson 1994), it should be understood that 
there is a difference between preferential anatomic loss and preferential psychophysical 
loss which reflects the functional properties of ganglion cell subtypes (Sample 2001).  
The magnocellular ganglion cells (M cells) in the retina are principally, but not 
exclusively, responsible for the detection of motion and flicker (Breton & Drum 1989; 
Schiller et al. 1994).  M-cells account for only 10% of ganglion cells in the retina (Perry 
et al. 1984) therefore, testing cells of the M pathway might enable detection of early 
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glaucomatous loss whether or not glaucoma selectively damages ganglion cells of the 
magnocellular pathway.  Theoretically, testing the function of M-cells should be able to 
detect the earliest form of glaucomatous damage (Chauhan & Johnson 1999; Artes, 
Hutchison, et al. 2005). 
 
M-cells have been shown to have larger soma and thicker axons (Kaplan & Shapley 
1986) and are believed to be damaged first in the glaucomatous process (Quigley et al. 
1989; Alward 2000; Quigley et al. 1987; Dandona et al. 1991; Glovinsky, Quigley, et al. 
1991; Glovinsky, Quigley, et al. 1991; Silverman et al. 1990; Bullimore et al. 1993; Tyler 
1981).  M-cells are mediated by low spatial and high temporal frequencies (Kaplan & 
Shapley 1986). Hence the use of perimetric tests which utilize flicker (Johnson 2009; 
Harwerth et al. 1999; Tyler 1981; Lachenmayer et al. 1989; Horn et al. 1997) and 
motion (Silverman et al. 1990; Wall & Ketoff 1995; Bosworth et al. 1997) have been 
proposed for the early detection of glaucoma.  In glaucoma, abnormality in spatial and 
contrast sensitivity have also been described (Tyler 1981; Sample et al. 1991). 
Several techniques such as Frequency Doubling Technology (FDT), Flicker Defined 
Form (FDF) and Moorfields Motion Detection Test (MDT) have been developed that are 
aimed at selectively testing ganglion cells of the magnocellular pathway, and its cortical 
processing (Swanson et al. 2004).  However, in a study by Swanson et al. (2011) they 
looked at the differences in contrast gain between M and P cells using both SAP size III 
and the frequency doubling stimulus. They concluded that SAP size III is superior to the 
frequency doubling stimulus at preferentially stimulating cells of the magnocellular 
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pathway.  This casts doubt on the reason for the diagnostic performance of these new 
tests being related to preferential stimulation of the M-cells, and that higher order 
cognitive factors may play a more important role in determining their sensitivity to early 
disease. 
 
1.7.1 Frequency Doubling Technology (FDT) 
 
It has been proposed that FDT selectively tests magnocellular cells, by using a flicker 
detection task (Anderson & Johnson 2002; Quaid et al. 2005; White et al. 2002).  
However, FDT perimetry does not depend on the perception of the frequency-doubling 
illusion to detect visual field loss but on changes in contrast sensitivity of a flickering 
stimulus (Quaid et al. 2005; White et al. 2002). Masking experiments were able to 
establish that the diagnostic performance of FDT is more likely due to a cortical 
response than a retinal response (Quaid et al. 2005).  Studies have shown that the 
contrast sensitivity produced by the FD illusion is reduced in patients with glaucoma 
(King-Smith et al. 1994).  Hence, it may be an optimum means of detecting and 
monitoring glaucoma, especially in the early stages of the disease. FDT has been 
shown to be equally repeatable across all threshold estimates (Spry et al. 2003; Artes & 
Chauhan 2005b) and therefore also may be more suitable than SAP to measure 
progressive glaucomatous visual field loss (Spry et al. 2001; Chauhan & Johnson 1999). 
However, it should be noted that the repeatability is much greater than SAP in the 
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nearly normal range.  In addition the range of possible sensitivities is greatly reduced  in 
FDT, ensuring that the relative repeatability is difficult to compare with SAP. 
 
1.7.1.1 FDT:  Instrument Specifications 
 
Frequency Doubling Technology (FDT) is a perimetry-like technique which 
simultaneously exploits the utility of contrast sensitivity, spatial frequency and temporal 
modulation (Sponsel et al. 1998).  The FDT target is made up of a sinusoidal grating 
undergoing counterphase flicker (Sponsel et al. 1998).  The FD phenomenon is 
perceived when a high temporal frequency counter phase flicker is combined with a low 
spatial frequency sinusoidal grating (Sample et al. 1991; Garway-Heath, Caprioli, et al. 
2000; Verdon-Roe et al. 2006; Baez et al. 1995).  Thus, the subject perceives the 
stimulus as having twice the number of bands and each band is half the width of the 
original (Yu et al. 2003).  Figure 1.1 shows a schematic diagram of the FD illusion.  
However the perception threshold described above is not possible to be reliably 
measured clinically and therefore is not the threshold criterion used in FDT.  Instead, the 
flicker detection threshold is used, i.e. the patient is asked to respond to the presence of 
a flickering target rather than to the perception of 8 rather than 4 bars.  It is the flicker 
detection threshold values that are used in the FDT normative values (Baez et al. 1995). 
 21 
 
Figure 1.1:  Schematic diagram of the Frequency Doubling Illusion.   
 
1.7.1.2 FDT:  Test Procedures 
1.7.1.2.1 FDT:  MOBS 
 
The full threshold test on the initial commercially available FDT screening instrument 
(FDT I) uses the Modified Binary Search (MOBS) test procedure (Turpin et al. 2002a; 
Tyrrell & Owens 1988).  The FDT is programmed to present a 10o stimulus with a spatial 
frequency of 0.25 cycles/deg and a temporal frequency of 25Hz.  A range of possible 
thresholds sets the upper and lower thresholds for the patient at each test location.  An 
average contrast value of the upper and lower threshold limit is calculated as the target 
contrast for the initial presented stimulus.  The patient’s response to the target 
determines the interval from which the contrast for the proceeding stimulus at that 
<4 cycles/degree 
>15 Hz counterphase flicker 
 
 22 
location will be calculated.  This reversal is continued until the difference between the 
upper and lower threshold is equal to or less than a predetermined interval (Tyrrell & 
Owens 1988); this information is used to calculate the threshold values.  An advantage 
of MOBS is that it can recover quickly from response error and it can make large jumps 
to remain close to the correct location of threshold (Tyrrell & Owens 1988). 
 
1.7.1.2.2 FDT vs SAP 
 
FDT has demonstrated a superior performance to SAP for the detection of early disease 
and comparable performance in later-stage disease (Johnson & Sample 2003).  
Abnormalities on FDT perimetry have been shown to precede detectable SAP damage 
by several years (Kim et al. 2007; Landers et al. 2003; Medeiros et al. 2004).  High 
sensitivity and specificity values have been shown with the FDT in early, moderate and 
late stages of glaucoma (Cello et al. 2000).  Despite its short duration as compared with 
conventional perimetry tests (Turpin et al. 2002b), MD and PSD values of FDT 30-2 
show a strong linear correlation with that of the Humphrey 30-2 technique (Sponsel et 
al. 1998); thus promising a possibility that FDT can be used to detect and differentiate 
the severity of glaucomatous visual field loss (Cello et al. 2000). 
 
Several studies have concluded that FDT is a promising screening tool for early 
glaucoma (Alward 2000; F. A. Medeiros et al. 2004; Cello et al. 2000; Trible et al. 2000; 
Johnson & Samuels 1997; Quigley 1998) and can be effective at detecting moderate to 
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severe cases of glaucoma (Alward 2000; Cello et al. 2000; Trible et al. 2000).  A 
longitudinal study looking at the rates of change in FDT PSD values showed that FDT 
may be useful for risk stratification in patients with suspected glaucoma and evaluation 
for glaucoma progression (Meira-Freitas et al. 2014).  FDT is an attractive alternative to 
SAP in the clinical setting because the test is more resilient to refractive errors and blur 
(Alward 2000; Cello et al. 2000), it has a large dynamic range, and the threshold test 
strategies are short in duration (Cello et al. 2000; Medeiros et al. 2004).  Good 
repeatability (Spry et al. 2003) and high sensitivity and specificity values (Cello et al. 
2000; Medeiros et al. 2006) have been shown with the FDT in early, moderate and late 
stages of glaucoma.    
 
The Matrix, also known as FDT II (Welch Allyn, Skaneateles Falls, NY; Carl Zeiss, 
Meditec, Dublin CA) is an updated version of the FDT; it was developed as a means of 
improving efficiency and accuracy.  In comparison to FDT, the Matrix uses a smaller 
stimulus size, allowing for more test locations to be tested thereby giving more detail on 
the spatial distribution of the visual field loss (Artes, Hutchison, et al. 2005). The 
commercially available Matrix is programmed to present a 5º stimulus with a spatial 
frequency of 0.5 cycles/deg and temporal frequency of 15Hz on a background 
luminance of 100 cd/m2.   
 
 
1.7.1.2.3 FDT: ZEST 
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Threshold values for the Matrix are calculated using an adaptation of the Zippy 
Estimation of Sequential Threshold (ZEST) procedure (Artes, Hutchison, et al. 2005; 
McKendrick 2005).  At each test location, 4 stimuli are presented, each with a 
predetermined intensity and corresponding probability density function (pdf) curve (King-
Smith et al. 1994; Turpin et al. 2002a), which estimates the probability of subsequent 
threshold values based on previously collected data; the pdf curve is modified for the 
next presentation with respect to the patients’ response (“seen” or “not seen”) (Artes, 
Hutchison, et al. 2005).  The 15 possible combinations of “seen/not seen” responses to 
the 4 stimuli presented determine the threshold estimates ranging from 0 to 38 dB 
(Artes et al. 2005), i.e. a frequency-of-seeing curve is obtained (King-Smith et al. 1994).  
Maximum-likelihood strategies are used to measure threshold values (Turpin et al. 
2002a), by presenting only 4 stimuli at each location.  This is why the test duration is 
independent of disease severity (Artes et al. 2005). 
 
1.8 Flicker Defined Form 
 
1.8.1 FDF:  Instrument Specifications 
 
The Heidelberg Edge Perimeter (HEP; Heidelberg Engineering, Germany) is a new 
perimetry instrument which provides both SAP and Flicker Defined Form (FDF) 
techniques (Flanagan et al. 1994; Ramchandran & Rogers-Ramchandaran 1991; 
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Livingstone & Hubel 1987).  FDF is an illusionary stimulus, capable of preferentially 
stimulating the magnocellular pathway and is generated when a background of random 
dots flickers at a high temporal frequency (15 Hz) in counterphase with a 5º stimulus 
region (Heidelberg Engineering, 2010).  The mean luminance of the background is set 
at 50 cd/m2, the background and stimulus dot luminance differ from the mean luminance 
by a set amount known as the amplitude.  The counterphase flickering of the 
background and stimulus dots gives rise to the illusion of a grey circle against a mean 
luminance background (Heidelberg Engineering, 2010) (Figure 1.2).  Changes in the 
amplitude of the background and stimulus dots creates stimuli with different contrasts.  
FDF is believed to predominantly stimulate RGCs of the magnocellular pathway 
because the illusion is not perceived at chromatic luminance and is resistant to blur (up 
to 6D) (Heidelberg Engineering, 2010).  Thus, it may be a good indicator for early 
glaucoma damage.  It is likely that the illusion is cortically generated and requires 
involvement of the entire dorsal stream to be perceived.  Sensitivity of FDF improves 
with increasing temporal frequency, eccentricity, dot density, target size and target area 
(Quaid & Flanagan 2005).   
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Figure 1.2:  Schematic Diagram of Flicker Defined Form 
 
1.8.2 FDF: Test procedures 
 
1.8.2.1 FDF: ASTA 
 
The Adaptive Staircase Thresholding Algorithm (ASTA) (Heidelberg Engineering, 2010) 
is an algorithm employed by the FDF that uses likelihood estimates from normal data 
distributions to determine the end point of threshold estimates.  In each quadrant, seed 
points located at 15º by 15º are measured using a 4-2-2 dB algorithm.  Neighbouring 
points then use the estimated sensitivity calculated at the seed points to complete a 2-2 
dB staircase.  If the crossings at each point lie within that of the expected age-matched 
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limits, further testing at that location is terminated.  If locations appear significantly 
reduced or different from neighbouring points within the same hemifield, they will be 
retested. 
 
The FDF ASTA Standard algorithm shows equivalent test-retest variability throughout 
the dynamic range to that of SAP (Heidelberg Engineering, 2010) .  FDF has been 
shown to detect glaucomatous damage when no defect was detected by SAP (Horn et 
al. 2016; Hasler & Stürmer 2012; Reznicek et al. 2015). 
 
1.9 Moorfields Motion Displacement Test (MDT) 
 
1.9.1 MDT:  Instrument Specifications 
 
Moorfields MDT is a new perimetric motion-displacement test used to diagnose 
glaucoma in the early stages (Verdon-Roe et al. 2006).  Moorfields MDT uses 32 lines 
each scaled to the ganglion cell density (Garway-Heath et al. 2000; Garway-Heath et al. 
2000) at its corresponding retinal location defined by the Garway-Heath map (Garway-
Heath, Poinoosawmy, et al. 2000) of the anatomic relationship between the visual field 
and optic nerve head (Figure 1.3).  The white lines (124 cd/m2) are presented on a grey 
background (10 cd/m2) and undergo brief lateral displacements of different magnitudes; 
10 random displacements ranging from 0 to 18 minutes of an arc displaced at 2.5 Hz 
(Baez et al. 1995).  These displacements give rise to the sensation of motion (Scobey & 
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Horowitz 1976). Like other perimetry techniques, the patient is asked to fixate on a 
centrally located target and press a button every time he or she detects a line on the 
screen to move.  The threshold, measured in minutes of arc, is the minimum 
displacement detected at each test location (Baez et al. 1995); the smaller the 
displacement detected, the greater the sensitivity at that location.  The ability to detect 
motion is the first to diminish in patients with glaucoma (Silverman et al. 1990) hence, 
the MDT proposes ideal for early detection of the disease. 
 
MDT has been shown to be more sensitive to glaucoma detection than SAP (Baez et al. 
1995; Fitzke et al. 1987; Fitzke et al. 1989; Ruben & Fitzke 1994; Poinoosawmy et al. 
1992) and less effected from cataract than either SAP or FDT (Membrey et al. 1998; 
Bergin et al. 2011). 
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Figure 1.3: Diagrammatic representation of the MDT testing screen.  The open squares represent the 
locations of the stimulus; each stimulus size corresponds inversely to the density of the receptor cells at 
that location.  The closed oval represents the blind spot. 
 
1.9.1.1 MDT: WEBS 
 
A weighted binary search (WEBS) threshold strategy is employed by the MDT to 
measure retinal sensitivity.  Each time the patient responds to a detection of motion, a 
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frequency of seeing curve is generated and used to calculate the threshold at that 
location (Membrey et al. 1998).  
 
1.10 Sensitivity Values 
 
Threshold and visual sensitivity, as measured by decibels (dB), are inverse functions.  
The dB scale is a logarithmic scale that is inversely related to luminance; each dB is 
equal to 0.1 log units with SAP, 0.05 log units with the Matrix (Artes, Hutchison, et al. 
2005) and 0.1/√2 log units for the FDF.  For the most part, neighbouring points in the 
visual field have similar thresholds (Heijl et al. 1980).  Moorfields MDT measures 
sensitivity in minutes of arc (MinArc) ((Moorfield Eye Hospital 2015).  The probability of 
seeing a stimulus presented at threshold is 50% (Turpin et al. 2002a; Turpin et al. 
2002b). 
 
1.11 Reliability Parameters 
 
Sensitivity thresholds are influenced by patients’ response fluctuations, experience, and 
fatigue (Bebie et al. 1976; Wild et al. 1989).  In order to accurately evaluate visual field 
loss with perimetry tests, it is crucial to know how reliable the test results are.  Reliability 
depends to a great extent on the patient’s ability to consistently perform the perimetric 
task (Delgado et al. 2002; Bickler-Bluth et al. 1989; Bengtsson 2000) and the 
reproducibility of its results (Bengtsson 2000).  Fixation losses (FL), false positive (FP), 
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and false negative (FN) calculations, as reported on the perimetry test printout, are an 
indication of the reliability and validity of the test.   
 
Fixation losses provide a relative idea of how well the patient kept his or her eye fixed 
on the fixation target during the test.  Throughout the test, at random intervals, a 
stimulus is projected in the area of the blind spot where the stimulus should not be seen 
(the instrument locates the area of the blind spot at the beginning of the test) (Drance & 
Anderson 1985) at maximum intensity; the number of times the patient reports seeing 
such stimuli is recorded alongside the other reliability indices (Heijl & Patella 2002; Cello 
et al. 2000).  This method is known as the Heijl-Krakau method (Heijl & Patella 2002) for 
determining fixation loss and is employed by SAP and FDT.  The FDF calculates fixation 
loss by using a video eye tracker to monitor eye movements; any movement greater 
than 5 degrees from central fixation is recorded as loss of fixation (Heidelberg 
Engineering GmbH, 2010).   
 
The false positive rate (FP) is presented as a ratio of the total number of times the 
subject responds without a stimulus being presented to the total number of times the 
instrument pauses without presenting a stimulus (Heijl et al. 1989).  A patient is termed 
“trigger happy” when he/she has a high false positive rate, i.e. frequently clicks the 
button when no stimulus is presented.  False negative errors usually result when the 
subject fails to respond to a distinctly visible stimulus (Heijl & Patella 2002) in a location 
outside of the determined blind spot.   
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The false negative rate (FN) is presented as a ratio of the total number of times the 
subject fails to respond when a stimulus of 9 dB higher than the previously determined 
threshold at that location is presented to the total number of such presentations (Heijl et 
al. 1989), i.e. failing to respond to stimulus with 100% contrast.  In the presence of 
severe visual field loss, FN is not used to define reliability due to the low number of 
catch trials (Zalta 1991).    
 
The SITA algorithm calculates FP and FN differently than described above.  False 
positives are calculated by recording positive responses when none are expected, i.e. 
within the minimum reaction time interval after a stimulus is shown (de Boer et al. 1982).  
False negatives are calculated based on the patient’s pattern of responses after the test 
is completed (Olsson et al. 1988).  Data from FP and FN defined in this way are 
combined and the maximum likelihood method is used to calculate FP and FN 
responses as a percentage (Olsson et al. 1988).  This method of estimating the 
frequency of FP and FN responses helps reduce testing time by reducing the number of 
presentations.  Moorfields MDT only calculates FP and it does this by counting the 
number of responses that were recorded within 180ms from the stimulus presentation, 
the physiological minimum response time, against the total number of stimulus 
presentations (Olsson et al. 1997). 
 
Vertex Monitoring and Gaze Tracking are features available on HFA II and HEP.  The 
former ensures that the patient’s eye is centered behind the lens at a distance that 
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allows for greatest focus of the stimulus, eliminating the trial lens as a possible source 
for unreliable results.  The latter is used to determine the patients’ fixation during the 
test.  This is done by using real-time image analysis.  A gaze tracking graph is displayed 
on the printout where deviations in gaze are indicated by a line which extends upwards 
(Heijl & Patella 2002); the proportion of the spike is proportional to the amount of fixation 
loss to a maximum of 10 degrees (Heijl & Patella 2002).  
 
1.12 Statistical Plots 
 
Probability maps are used to evaluate the normality of the data (Heijl et al. 1989).  They 
compare the threshold values of the patient with that of the age-matched normal 
database, if one is available for the technique.  
 
Total deviation (TD) values and its related probability plot are calculated on techniques 
that have a normal database available.  The TD plot is composed of positive and 
negative integers which correspond to the difference in sensitivity between the subject 
and age-matched normal data at each point of the visual field (Heijl & Patella 2002; 
Bernhard et al. 1993).  TD plots are useful because they accentuate areas of the visual 
field which fall outside the normal range (Heijl & Patella 2002).  Its corresponding 
probability map indicates how different the given results are from that of the normal 
(Walsh 1990; Werner et al. 1989). 
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A pattern deviation (PD) plot and its related probability plot are also calculated with 
respect to a normal database.  This particular plot allows for the field test results to be 
compensated with respect to the subject’s height of the hill of vision (Heijl & Patella 
2002), i.e. it eliminates defects caused by a generalized shift in MD (Bernhard et al. 
1993).  Thus, it signifies the difference in shape of the measured hill-of-vision as 
compared with that of the normal population (Heijl et al. 1989).  This allows for 
differentiation of localized visual field loss from that resulting from age-related conditions 
such as small pupils and cataract formation (Heijl & Patella 2002).   
 
1.13 Global Indices 
 
Statistical analysis of visual fields has become useful in interpreting the results from 
automated perimetry (Brenton & Argus 1987).  Visual field indices are statistical review 
of the retinal light sensitivities which are designed to recognize and evaluate the extent 
of visual field damage (Chauhan et al. 1990).  They are used to facilitate interpretation 
of the results from a single perimetric examination (Chauhan et al. 1990).  It assists the 
interpreter with defining visual field loss by summarizing the data obtained from the test 
(Flanagan et al. 1993).  Visual field indices, Mean Deviation (MD) and Pattern Standard 
Deviation (PSD) are calculated based on previously acquired normal data (Trible et al. 
2000).  MD is calculated by averaging the deviation from normal for all points tested 
(Bickler-Bluth et al. 1989).  It quantifies overall change of visual field loss with respect to 
normal data of age-matched controls (Lindenmuth et al. 1990; Spry & Johnson 2002; 
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Trible et al. 2000; Katz et al. 1991).  Pattern standard deviation (PSD) measures the 
extent to which the tested field deviates from the shape of the “normal hill of vision” 
(Bickler-Bluth et al. 1989).  It is an index for showing localized change in the visual field 
(Lindenmuth et al. 1990; Trible et al. 2000; Katz et al. 1991). 
 
The visual field index (VFI) is a newer global index available on HFA, which evaluates 
the level of visual function (Giraud et al. 2010) and has been shown to correlate linearly 
with MD calculations (Artes et al. 2011).  The VFI calculates the overall severity of the 
visual field and, unlike MD, its calculation is weighted depending on eccentricity with 
respect to ganglion cell density.  The index is given as a percentage from 0 to 100 
where 0% represents severe glaucoma and 100% represents a normal visual field.  
Studies are underway to determine its effectiveness in predicting glaucoma progression 
(Bengtsson et al. 2009; Ernest et al. 2016; Banegas et al. 2016).  
 
1.14 Structural Assessment 
 
In the past, stereo photography was used to evaluate and document the structure of the 
optic nerve head.  Analysis of stereophotos have been shown to have great inter-
variability among non-expert and expert observers (Breusegem et al. 2011).  Today, 
imaging of the ONH and RNFL by computerized methods has become common practice 
in addition to visual field tests (Greenfield 2002; Zangwill & Bowd 2006; Stein et al. 
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2012) however, diagnosis by expert observer still remains the best reference standard 
(Prum et al. 2016).   
 
1.14.1  Scanning Laser Tomography 
 
The Heidelberg Retina Tomograph (HRT) (Heidelberg Engineering GmbH, Heidelberg, 
Germany) uses the principles of confocal scanning laser ophthalmoscopy (CSLO) to 
acquire images of the optic nerve head (ONH) and macula (Weinreb 1993) and 
measure height of the internal limiting membrane (Eid et al. 1997).  Figure 1.4 is a 
schematic diagram of the CSLO principle.  It provides three-dimensional images of the 
optic disc and peripapillary retina for the detection and monitoring of changes in 
glaucoma (Chauhan et al. 2000).  The HRT has been shown to acquire repeatable and 
reliable measurements of the ONH (Mikelberg et al. 1993; Rohrschneider et al. 1994; 
Chauhan et al. 1994), provide reasonable levels of sensitivity and specificity (Mikelberg 
et al. 1995; Bathija et al. 1998; Uchida et al. 1996; Zangwill et al. 2007) and be in 
agreement with an ophthalmologist’s clinical examination (Yaghoubi et al. 2015). 
 
The HRT III uses a 675 nm diode laser as a light source which measures the reflectivity 
of 147, 456 points in 0.024 seconds per plane. In summary, a pinhole is placed in front 
of the light source and the laser beam is focused onto the retina at a predetermined 
depth by use of a converging lens. The laser scans an image field 15˚ horizontally and 
15˚ vertically along the xy-plane of the retina in a raster pattern and a 2-dimensional 
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cross-section of the ONH is obtained, composed of pixels that are in and out of focus.  
The laser is successively lowered along the z-axis in small increments and each xy-
plane is scanned.  The scan depth is automatically selected and ranges from 1.0mm to 
4.0mm.  For each millimeter along the z-axis, 16 xy-planes are scanned; the data are 
then computed to form a 3-dimentional image.  Magnification errors between patients 
are corrected by inputting the corneal curvature measurements prior to obtaining the 
measurements.   
 
 
 
 
Figure 1.4:  Schematic diagram of confocal scanning laser ophthalmoscopy (CSLO) as utilized by 
Heidelberg Retina Tomograph (HRT).  A 675 nm diode laser is focused on the retina at a predetermined 
depth.  The xy-plane of the retina is scanned in a raster pattern.  The laser is successively lowered along 
the z-axis in small increments; for every 1 mm of depth along the z-axis, 16 xy-planes are scanned.  All 
scanned planes are then computed to form a 3-dimensional image. 
 
The HRT software computes such indices as neuroretinal rim area, cup volume, NFL 
thickness, and cup-shape measure (Mikelberg et al. 1993).  Cup shape measure, as 
calculated by the HRT, is an important parameter to detect change (Brigatti & Caprioli 
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1995) and most predictive when comparing normal and glaucomatous optic discs (Iester 
et al. 1997).   
 
 In comparison to the HRT II, HRT III, has a larger normative database and introduction 
of ethnic-specific stratification, a new classification system, the Glaucoma Probability 
Score (GPS), and an improved image scaling and alignment algorithm (Strouthidis & 
Garway-Heath 2008). 
 
The HRT II & III are equipped with software, which determined whether a given ONH 
falls within the age-matched normal range.  Moorfields regression analysis (MRA) is a 
calculation based on comparison of the subject’s rim area with that of a normal 
database (Wollstein et al. 1998).  The Glaucoma Probability Score (GPS) classification 
algorithm (Swindale et al. 2000) discriminates between normal and glaucomatous ONH 
using a mathematical model of ONH shape for comparison purposes (Strouthidis & 
Garway-Heath 2008).  It is operator independent, as it does not need a contour line to 
be drawn around the ONH; the option for drawing a contour line is also available. 
Sensitivity and specificity of GPS and MRA are similar (Strouthidis & Garway-Heath 
2008).  Optic disc size has been shown to have a significant effect on GPS classification 
but a lesser effect on MRA classification (Coops et al. 2006; DeLeón Ortega et al. 2007; 
Zangwill et al. 2007; Ferreras et al. 2007).  Disease severity influences GPS and MRA 
classification (Strouthidis & Garway-Heath 2008).  GPS has higher sensitivity and lower 
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specificity than MRA in patients with mild glaucomatous VF loss (Strouthidis & Garway-
Heath 2008); MRA better discrimination in severe glaucoma (Ferreras et al. 2007). 
 
Previous studies have shown that HRT parameters are a good indicator of 
glaucomatous ONH damage (Iester et al. 1997).  In studies where HRT was used to 
measure structural damage in early glaucoma, damage is detected more readily in 
larger optic discs than smaller ones (Emdadi et al. 1998; Iester et al. 1996).  Hence, 
patients with reproducible focal visual field defects that have small optic discs can have 
structural damage that is not detected by the HRT (Emdadi et al. 1998) and underlies 
the importance of combining structural and functional testing for glaucoma detection and 
management. 
 
The amount of neuroretinal rim loss as measured by the HRT has showed the best 
correlation, among the other parameters, with histologic optic nerve fiber count in a 
study with monkeys (Yucel et al. 1998). 
 
1.14.2  Optical Coherence Tomography  
 
Optical Coherence Tomography (OCT) is a non-invasive imaging technique which 
allows for cross-sectional imaging of the human retina (Guedes et al. 2003) and 
resolution of the individual layers.  The instrument was initially used for measuring 
RNFL thickness but recent improvements have allowed it to quantitatively examine the 
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optic disc and retina (Medeiros et al. 2005) to evaluate ONH topography and macular 
thickness for diagnosis (Schuman et al. 1995a; Schuman et al. 1995b) and follow-up of 
patients with glaucoma (Medeiros et al. 2005).   
 
The OCT uses low-coherence interferometry to produce cross-sectional images of the 
retina with quantitative assessment of retinal and retinal nerve fiber layer (RNFL) 
thickness (Greenfield et al. 2003; Schuman et al. 1995a).  The original OCT was based 
on a time-delay interferometry procedure; more recent developments have incorporated 
spectral-domain procedures. 
 
In the time-domain OCT (TD-OCT) a low coherence light beam is divided by an optical 
beam splitter into a reference beam and a measurement beam and is directed into a 
Michelson interferometer set-up (Figure 1.5).  The reference beam is directed to a mirror 
whose position and distance is known; the measurement beam is directed into the 
patient’s eye where it is reflected from the surface different microstructures of the retina.  
Both the reference and measurement beams are reflected to a mirror where they 
recombine and are transmitted to a photosensitive detector.  The time delay between 
the two beams is used to calculate the thickness of different intraocular structures at the 
point along the z-axis of the retina. 
 
Measuring RNFL thickness by OCT is influenced by the reflective properties of the ILM 
(Hess et al. 2005).  The ILM can vary greatly in its optical properties, especially in cases 
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of glaucomatous damage hence, loss of reflectivity of NFL in advanced glaucoma cases 
may contribute to the inaccuracy of thickness as measured by the OCT (Pons et al. 
2000). 
 
 
 
 
Figure 1.5:  Schematic diagram of the Optical Coherence Tomography (OCT).  The infrared light emitted 
from the source is divided by an optical beam splitter into a reference beam and a measurement beam.  
The reference beam is reflected to a reference mirror and then back to the beam splitter.  The 
measurement beam is reflected into the patient’s eye and reflected back from surfaces of the different 
ocular structures.  This reflected measurement beam is composed of multiple echoes from each of the 
different intraocular surfaces.  The time delay between the reflected beams is used to calculate the 
thickness of the different intraocular structures.  
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It has been shown that OCT provides reliable and reproducible measurements of the 
RNFL, retinal thickness and optic nerve head in human eyes (Blumenthal et al. 2000; 
Carpineto et al. 2003; Schuman et al. 1996).   
 
Traditional OCT is the time domain OCT (TD-OCT) (Huang et al. 1991; Hee et al. 1995; 
Puliafito et al. 1995; Thomas & Duguid 2004) which measures thickness of the retina 
with respect to a reference beam after a longitudinal translation in time (Forte et al. 
2009).  Spectral domain OCT (SD-OCT) measures retinal thickness as a function of 
optical frequencies which requires less time for data acquisition and allows for more 
measurements per unit area which provides greater resolution (Drexler et al. 2003; 
Wojtkowski et al. 2005; Wojtkowski et al. 2004; Koizumi et al. 2008; Knight et al. 2009).  
Both TD-OCT and SD-OCT are used to detect and monitor glaucoma.  It has been 
shown that SD-OCT can better detect preperimetric glaucoma than TD-OCT (Jeoung et 
al. 2014).  However, a study by Schrems et al. (2015) found high levels of agreement 
between TD- and SD-OCT. 
 
A review by (Abe et al. 2015) demonstrated that the SD-OCT has the potential for 
serving as a “biomarker” for glaucomatous damage.  Recent advances in OCT 
technology such as OCT Angiography may be useful for the detection and monitoring of 
progression in glaucoma (Jia et al. 2015.; Liu et al. 2015). 
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1.14.3  Scanning Laser Polarimetry 
 
Scanning laser polarimetry provides an objective means of measuring RNFL thickness. 
The GDx VCC (Laser Diagnostic Technologies, San Diego, CA) is a scanning laser 
polarimeter, which measures thickness of the nerve fiber layer in the peripapillary area 
by using the birefringent properties of the RGC axons (Weinreb et al. 1995b).  It 
provides quantitative measurements of the RNFL (Weinreb et al. 1990; Weinreb 1995a) 
that correspond to the properties of the RNFL (Weinreb et al. 1995a).  RNFL is known to 
be thicker in the superior and inferior peripapillary regions (Morgan & Waldock 2000; 
Varma et al. 1996; Dichtl et al. 1999), the GDx has been shown to agree with these 
measures in normal subjects (Weinreb, Shakiba & Zangwill 1995; Morgan & Waldock 
2000; Tjon-Fo-Sang et al. 1996; Brandt 2004).  SLP provides a good and objective 
method for RNFL thickness evaluation (Chen et al. 2009) as it has shown a good 
correlation with histological measurements (Blumenthal et al. 2009; Cohen et al. 2008).   
 
The GDx uses a 780-798 nm diode laser which acquires its measurements in 0.8 
seconds.  It is based on the principle that, as polarized light passes through the 
microtubules of the nerve fiber layer the phase shift, or retardation, caused by the 
birefringent properties of the RNFL, is proportional to its thickness (Weinreb et al. 1990), 
i.e. birefringence due to the oriented cylindrical structure of RGC axons is proportional to 
the histologically measured RNFL thickness (Figure 1.6).  Areas that are thicker have 
more retardation than thinner nerve fiber layers (Quigley et al. 1982).   
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However, birefringence, as measured by SLP, is also influenced by the density and/or 
composition of axonal organelles (Hemenger 1989; Zhou & Knighton 1997), which vary 
around the ONH (Huang et al. 2004) and may vary during different stages of the 
disease (Weinreb et al. 2003; Bagga et al. 2003; Guedes et al. 2003; Mohammadi et al. 
2004).  Although this technique was a promising predictor of glaucomatous visual field 
loss, birefringence of the cornea has a great effect on the calculation of RNFL thickness.  
The Variable Corneal Compensation (VCC) algorithm was introduced to compensate 
partially for the corneal birefringence.  The VCC cancels out the specific effects of the 
cornea as per patient (Zhou & Weinreb 2002).  This has helped improve glaucoma 
detection (Zhou & Weinreb 2002; Weinreb et al. 2003; Greenfield, Knighton, et al. 2003; 
Medeiros et al. 2003; Greenfield et al. 2002; Choplin et al. 2003) and shows a stronger 
correlation with other structural measures (Reus et al. 2006; Bagga et al. 2003; 
Schlottmann et al. 2004).  Atypical retardation patterns, ones that do not follow the 
normal birefringence pattern of highest retardation in the superior and inferior sectors 
(Bagga et al. 2005), are seen in 25% and 51% of normal and glaucomatous eyes, 
respectively (Bagga et al. 2005).  These atypical retardation patterns result in poor 
signal-to-noise ratios (Susanna & Medeiros 2006) and result in diagnostic discrepancy.  
The Enhanced Corneal Compensation (GDx ECC) algorithm was developed to 
overcome this problem by improving the neutralization of the atypical retardation 
patterns (Bagga et al. 2005; Medeiros et al. 2007).  This has improved the detection of 
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glaucoma in patients with severe cases of atypical retardation patterns (Medeiros et al. 
2007; Mai et al. 2007). 
 
Figure 1.6:  Schematic Diagram of GDx VCC 
 
 
The GDx VCC calculates an index called the nerve fiber indicator (NFI) which integrates 
the overall indices of the RNFL.  It ranges between 0 and 100, with 100 representing 
patients with severe glaucoma.  The NFI on the GDx VCC is the best discriminating 
parameter between normal and glaucomatous eyes (Reus & Lemij 2004a). 
 
 
 
1.15 Progression in Glaucoma 
 
One of the most difficult tasks in the management of glaucoma is detection of 
progression (Banegas et al. 2016; Haymes et al. 2005; Vesti et al. 2003), which relies 
on the detection of a worsening structural and/or functional measurement (European 
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Glaucoma Society 2008).  Early detection of glaucoma progression is just as important 
as early detection of the disease (Ansari et al. 2000), as progression can significantly 
impact visual function (Gupta & Weinreb 1997) and quality of life (Abe et al. 2016).  
Progression is determined by either i) trend analysis, which looks at regression of a 
parameter over time, or ii) event analysis, which performs a point-by-point comparison 
between baseline and follow-up examinations (Vesti et al. 2003).   
 
For progression to be detected on any instrument, measurement “noise” must be 
distinguished from change due to glaucoma (Strouthidis et al. 2006).  As Spry and 
Johnson have said in an article outlining the guidelines for the clinical management of 
glaucoma, “developing a standardized method of determining glaucomatous 
progression and the rate of progression remains a challenge” (Spry & Johnson 2002).  
Several studies have shown that the difference in test performance to detect glaucoma 
progression is dependent on the stage of the disease (Leung et al. 2010; Vizzeri et al. 
2010; Kerrigan-Baumrind et al. 2000; Suh et al. 2012; Rao et al. 2011; Banegas et al. 
2016). 
 
Several statistical approaches have been developed and several criteria have been 
used with major clinical trials on determining visual field progression (AGIS Investigators 
1994; Anderson et al. 1998; Gordon & Kass 1999; Leske et al. 1999; Spry & Johnson 
2002).  These differences in methodology give rise to difficulties in comparing the 
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results of the studies to each other, in addition to the absence of a gold standard (Nouri-
Mahdavi et al. 1997; McNaught et al. 1996).   
 
Progression studies are cross-sectional and determine the average of many patients 
seen at one time (Artes 2008) thus, the amount of change over time will follow a 
characteristic pattern (Bengtsson & Heijl 2008).  Individually, change over time as 
measured for each patient may be different (Artes 2008) as only extreme cases may 
follow this pattern (Artes 2008; Artes & Chauhan 2005a). 
 
1.15.1 Functional Progression 
 
The key to managing a patient with glaucoma is to determine whether or not the 
patient’s visual status has progressed (Johnson 2009); changes in visual field have 
been used to determine progression of glaucoma (AGIS Investigators 1994; Anderson 
et al. 1998; Gordon & Kass 1999; Leske et al. 1999; Glaucoma & Group 2006; Musch et 
al. 1999).  Various methods have been used to define and classify glaucomatous visual 
field defects (AGIS Investigators 1994; Katz 1999; Anderson et al. 1998; Gordon & Kass 
1999; Leske et al. 1999), and progression (Katz et al. 1997; Katz 1999; Anderson et al. 
1998; Leske et al. 1999; Bengtsson, Lindgren, et al. 1997; Fitzke et al. 1996; Smith et 
al. 1996).  Detecting glaucomatous visual field progression is a challenge as it is difficult 
to detect true change in visual status (signal) from variability (noise) (Bebie et al. 1976; 
Artes, Nicolela, et al. 2005).  Variability can be both within (short-term fluctuation) and 
 48 
between (long-term fluctuation) tests (Flammer et al. 1984; Stewart & Hunt 1993).  
Other factors such as eccentricity (Heijl et al. 1987;  Heijl et al. 1989), defect depth (Heijl 
et al. 1989; Flammer et al. 1984), test duration (Heijl & Drance 1983), experience (Wild 
et al. 1989) and fatigue (Hudson et al. 1994) also contribute to the test’s variability.  The 
amount of initial visual field loss and both inter- and intra-test variability contribute to 
how well a specific method can detect progression (Flammer 1985).  For example, 
some methods may detect progression only in the early stages, while other methods 
detect progression when extensive damage already exists (Vesti et al. 2003). 
 
Trend analysis measures the amount of change from baseline using all tests that are 
available.  Several procedures use this method of analysis to measure visual field 
progression including, mean deviation, pattern standard deviation, PROGRESSOR 
(Viswanathan et al. 1997) and the visual field index (VFI) (Bengtsson & Heijl 2008).  MD 
and PSD indicate change over time of the overall visual field can accurately detect 
significant change if there is a general depression in sensitivity or a very large localized 
change that is evident when all the data points are averaged (Bengtsson & Heijl 2008; 
Viswanathan et al. 1997).     
 
The use of global indices to measure visual function and global statistics to measure 
structure may, however, be inadequate to follow more subtle progress changes as 
global measures cause loss of spatial information and result in poor sensitivity to identify 
localized change (Chauhan et al. 1990).  Thus, small localized changes in the visual 
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field will go unnoticed with this type of analysis.  PROGRESSOR looks at individual test 
locations over successive perimetric examinations using linear regression of sensitivity 
on time (Bengtsson & Heijl 2008). This method is very useful in determining localized 
change over time and has been shown to detect and predict future glaucomatous visual 
field loss (Viswanathan et al. 1997).   
 
The Humphrey Field Analyzer is equipped with the STATPAC software which calculates 
glaucoma change probability (GCP) as described by Artes et al (2011) and Heijl et al  
(1991).  GCP and glaucoma progression analysis (GPA) programs (Carl Zeiss Meditec, 
Inc., Dublin, CA) are statistical analysis software equipped in the HFA which compare 
baseline to follow-up examinations and flag points that lie outside of the 90% confidence 
interval in the total deviation and pattern deviation probability plots.  These calculations 
combine the first two visual field test results to obtain a mean baseline and then 
compare this calculated baseline to the subsequent tests as such they employ event 
analysis (Artes et al. 2011; Heijl et al. 1991; Spry & Johnson 2002).  If threshold values 
of the follow-up test are outside the 5th and 95th percentile of test-retest variability of 
stable glaucoma patients, then the points are highlighted as probable improvement or 
progression, respectively.  An advantage of this technique is that it can identify 
progression with as little as three visits (Spry & Johnson 2002).  On the other hand, the 
techniques allow only determination of change and do not calculate the magnitude or 
rate of change; the amount of change required to be considered as progressing must 
exceed the test-retest variability (Spry & Johnson 2002).  Patients with glaucoma have 
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greater test-retest variability making it more difficult for subtle changes to be noted as 
progression (Spry & Johnson 2002).  
 
In glaucoma, perimetry testing may be the only means of detecting progression in the 
later stages as the optic disc will no longer be a reliable or accurate indicator for 
progression (Katsumori et al. 1985), as minute changes in neuroretinal rim anatomy are 
difficult to quantify.  The problem in comparing methods of visual field progression is 
that there is no set gold standard (Nouri-Mahdavi et al. 1997).  There is weak evidence 
supporting the notion that SWAP and FDT are more sensitive than SAP at detecting 
progression (Demirel & Johnson 2001; Haymes et al. 2005).  Function specific perimetry 
tests become less sensitive with increasing loss of RGCs therefore SAP may not be the 
most sensitive technique to monitor glaucomatous progression at the end-stage 
(Chauhan et al. 2001).  
 
1.15.2  Structural Progression 
 
Progressive optic neuropathy is the hallmark of glaucoma (Fechtner & Lama 1999).  An 
alternative method to determining glaucomatous progression with visual fields is to 
clinically assess the characteristics of the optic nerve head (Spry & Johnson 2002).  
Characteristic traits of structural glaucoma progression include increasing ONH 
excavation and RNFL thinning (Drance 1975; Schwartz 1976; Spaeth et al. 1976). . 
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Event analysis (glaucoma change probability) and trend analysis (Moorfields regression 
analysis) appear to be the most commonly used procedures (Fingeret et al. 2005) in 
detecting structural progression.  HRT uses Topographic Change Analysis (TCA) to 
determine progression by comparing a 4x4 array of 16 pixels from baseline and follow-
up and determine whether or not the 16 pixels fall within the 95% confidence interval of 
variability (red worse, green better) (Sommer et al. 1977; Chauhan et al. 2000; Chauhan 
et al. 2001).  Both SLP and OCT use event analysis (Guided Progression Analysis) 
which compare baseline to follow-up images to determine change outside of the 95% 
confidence limit in the RNFL and ONH respectively (Alencar et al. 2010; Leung et al. 
2010). 
 
Changes in optic disc topography can be detected more readily than changes in visual 
function as assessed by SAP (Chauhan et al. 2001) in the early stages of glaucoma.  
This is supported by the OHTS where 52% of the patients who developed POAG 
showed structural signs of progression and only 7% later developed functional damage 
(Keltner et al. 2006).  
 
A study by Harwerth et al (2004) has shown a good correlation between structural and 
functional loss in experimental glaucoma when eccentricity factors are included. 
The study by Bowd et al (2006b) suggest that Stratus OCT RNFL thickness 
measurements may provide better cross-sectional representation of visual function than 
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HRT II and GDx VCC measurements however, these results may have been affected by 
the different normative database available for each instrument. 
 
Associations of RNFL/disc topography and visual sensitivity are dependent upon the 
instruments being tested, the locations being tested as well as the characteristics of the 
study population (Bowd et al. 2006).  The stage of the disease also plays a role in 
variability and repeatability of test parameters within each instrument (Michelessi et al. 
2015).  For example, one study compared the effects of glaucoma severity on 
repeatability of CSLO, SLP and OCT (DeLeón Ortega et al. 2007) and found that global 
RNFL and vertical C/D ratio as measured with GDX VCC and HRT III, respectively, was 
stable across disease severity; unlike rim area which increased with disease severity.  
These findings suggest that global RNFL and vertical C/D ratio be used to monitor 
glaucoma progression in the later stages as opposed to rim area. 
 
Imaging devices such as HRT, OCT and GDx VCC which identify glaucoma at the 
earliest signs of visual field damage have a sensitivity of 70% with 90-95% specificity 
with respect to clinical evaluation and results obtained from SAP 24-2 (Medeiros et al. 
2004; Zangwill et al. 2001; Ford et al. 2003) and both imaging devices and clinicians 
have the same ability to identify structural damage caused by glaucoma (Wollstein et al. 
2000; Mistlberger et al. 1999; Yaghoubi et al. 2015; Kourkoutas et al. 2007) and that 
imaging instruments can assist clinicians in diagnosing and monitoring glaucoma (Reus 
et al. 2007).   
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1.16 Rationale 
 
 
In summary, early detection of glaucomatous damage and its progression over time is 
one of the most important clinical challenges in glaucoma (Hood & Kardon 2007). Both 
perimetry and structural imaging tests are essential for the management of glaucoma 
(Garway-Heath 2007; Airaksinen et al. 1985; Airaksinen & Drance 1985).  The 
developments of new perimetry techniques and imaging instruments are aimed at 
providing optimum sensitivity and specificity in detecting the disease early and 
monitoring its progression.  We want to compare the diagnostic abilities of SAP, FDT, 
FDF and MDT to see which technique is better able to pick-up glaucomatous damage 
earlier also, compare these functional measures to structural measures of the HRT, 
OCT and GDx. 
 
1.17 Purpose 
 
A two-fold approach was taken to address the study purpose:  i) cross-sectional 
comparison of perimetry tests and imaging techniques to evaluate structure-function 
relationship between measures of RNFL, ONH and visual function, and ii) preliminary 
longitudinal comparison of perimetry tests and imaging techniques to determine which 
instrument being studied detects progression in patients with early stage glaucoma.  
The first part of this study was conducted as a multi-center study with four different 
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study sites.  However, the longitudinal study was conducted by only one of the four 
centers (Toronto, Ontario location).  In each study center, patients with glaucoma and 
control subjects were recruited based on the inclusion and exclusion criteria described 
below.  
 
The data collected were used to look at test-retest within techniques, the structure-
function relationship between the various imaging and structural tests, and to determine 
the ability of each technique to measure progression. 
 
 
1.18 Research Questions 
 
Does choice of perimetry affect repeatability and detection of characteristics of visual 
field abnormalities in patients with early stage glaucoma? 
Does there exist and structure-function relationship between RNFL and visual function? 
 
1.19 Objectives 
 
The global aim of this thesis is to determine whether or not visual function of the RGCs 
correspond to structure of the ONH and RNFL and which technique is more sensitive for 
the early detection of glaucoma.  The following perimetry techniques were used: i) SAP, 
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ii) FDT, iii) FDF, and iv) MDT; the following imaging instruments were used: i) HRT, ii) 
OCT, iii) GDx. 
 
The primary objectives of this study was to determine which perimetry technique, SAP, 
FDT, FDF, or MDT, is more reliable and sensitive to early detection of glaucoma and 
whether or not visual function as measured by these techniques corresponds to the 
ONH and RNFL structure as measured by the HRT, OCT and GDx. 
 
1.20 Hypotheses 
 
1. Function specific perimetry techniques show earlier and deeper defects than SAP. 
2.  HRT shows greater agreement with function specific perimetry techniques than with 
SAP. 
3.  There are differences in the structure function relationship of different ONH sectors. 
4.  There are differences in the structure function relationship of different ONH sectors 
between OCT, GDx VCC and measures of visual function. 
5.  Function specific perimetry shows more change in one year than SAP. 
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2. Methods 
 
2.1 Sample Size  
The sample size for this study was calculated with the following formula: 
 
η = 2[(a+b)2?2 
E2 
  
where η is the sample size, σ is the population standard deviation obtained from 
previous studies and E is the margin of error (maximum difference between techniques).  
Similar studies performed previously have reported σ =3.30.  For this study, we chose a 
95% confidence interval (α=0.05), power of 80% (β=0.80) thus a= 1.96, and b=0.842 
and E=1. 
 
Substituting these values into the equation we get: 
 
η = 2[(1.96+0.842)2(3.30)2 
12 
=171 
 
Although our sample size calculation indicates that an η of 171 will provide statistically 
significant results; however, 194 subjects were recruited for this study. 
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2.1.1 Study Sample Demographics 
 
Table 2.1 describes the study sample demographics recruited for the study.  All subjects 
were included in the test-retest study and a subgroup of these subjects were used for 
the structure-function and progression studies.  The details of these subgroups are 
described below.  The sample consisted of 104 males and 90 females, 95 glaucoma 
and 99 controls.  109 right eyes and 85 left eyes were included.  The age ranged from 
18 to 84 years with a mean age and standard deviation of 60.99 + 11.51 years. 
 
Table 2.1:  Study sample demographics for test-retest study. 
 
Table 2.2:  Study sample demographics for the subgroup of patients included in the study comparing HRT 
to SAP, FDT, FDF and MDT. 
 Ratio Average Maximum Minimum 
Males: Females 82: 75 --- --- --- 
Glaucoma: Control 70: 87 --- --- --- 
Eyes (Right: Left) 86: 71 --- --- --- 
Age (years) --- 59.99 + 11.24 78 18 
 
 Ratio Average Minimum Maximum 
Males: Females 104: 90 --- --- --- 
Glaucoma : Control 95: 99 --- --- --- 
Eyes (Right: Left) 109: 85 --- --- --- 
Age (years) --- 60.99 + 11.51 18 84 
Time Elapsed Between Visits (days) --- 88 + 27 1 109 
Time Elapsed Between Visits (weeks) --- 12 + 4 <1 16 
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Table 2.3:  Study sample demographics for the subgroup of patients included in the study comparing OCT 
and GDx to SAP, FDT, FDF and MDT. 
 
 
Table 2.4:  Study sample demographics for subgroup of patients included in the progression study. 
 
2.1.2 Inclusion/Exclusion Criteria 
 
Patients with characteristic glaucomatous visual field defects were considered as 
possible candidates for participation in the study.  Glaucomatous visual field defects 
were defined as defects within the visual field whose pattern reflected the anatomy of 
the RNFL.   
 
To be included in the study, the following criteria were:  i) HRT results with image quality 
standard deviation <40 microns, ii) reliable SITA SAP results, i.e. false positive and false 
negative rates of <15% and fixation loss <30%, iii) visual acuity of 6/12 or better in the 
study eye, iv) refractive error less than + 6.0 D sphere and/or less than + 3.0 D cylinder, 
v) tolerant to dilating drops, vi) able and willing to make the required visits, vii) able and 
willing to give consent and properly follow given instruction.  The subject was excluded 
 Ratio Average Maximum Minimum 
Males : Females 27 : 11 --- --- --- 
Eyes (Right : Left) 22 : 16 --- --- --- 
Age (Years) --- 64.82 + 11.50 85 30 
     
     
 Ratio Average Maximum Minimum 
Males : Females 27 : 11 --- --- --- 
Eyes (Right : Left) 22 : 16 --- --- --- 
Age (Years) --- 64.82 + 11.50 85 30 
Time Elapsed Between Visits (days) --- 420 + 39 510 367 
Time Elapsed Between Visits 
(weeks) 
 60 + 6 73 52 
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from the study if he or she had at least one of the following conditions: i) a suspicion or 
actual defect in the visual field of the eye being tested that was explained by the 
patients ocular status or history for a condition other than glaucoma (‘glaucoma’ 
subjects only), ii) any history of disease or use of medication that may affect visual field 
reliability and/or imaging of the RNFL, e.g. media opacities such as dense cataract, iii) 
past history of stroke or diabetic retinopathy, iv) previous ocular surgery other than 
uncomplicated cataract surgery.  For glaucoma subjects, the eye with the least damage 
was chosen as the study eye; for control subjects, the eye to be tested was chosen at 
random.   
 
For the Toronto, Ontario site, the glaucoma subjects were recruited from the 
Ophthalmology Clinic of Dr. Christoph Kranemann Medicine Professional Inc. based on 
judgment by the treating ophthalmologist.  Control subjects were recruited from the 
Optometry Clinic of Dr. Areef Nurani based on judgment by the treating optometrist.  
The control group was recruited to calculate sensitivity and specificity values of the 
techniques used.  In most of the data analysis, the data from both the glaucoma and 
control subjects were pooled into a single database. 
 
2.2 Definition of Disease Stage 
For the purposes of this study, the Heidelberg Retina Tomograph and Goldmann 
Applanation Tonometry were used to categorize control subjects and those with early 
stage glaucoma. 
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The patients were classified into the ‘Control’ group if his or her HRT results were 
classified as “Within Normal Limits” and IOP was <21 mmHg without treatment.  The 
patients were classified into the ‘Glaucoma’ group if his or her HRT results were 
classified as “Outside Normal Limits” with rim area >0.8 mm2 and disc area “Within 
Normal Limits”, and IOP measured >21 mmHg before they had started any treatment 
and <26 mmHg at time of testing. 
 
2.3 Ethics 
 
The study was approved by the University of Waterloo, Office of Research Ethics.  
Written consent was obtained from each of the subjects prior to enrollment in the study. 
 
2.4 Procedures 
 
Upon obtaining consent, subjects were given an ophthalmic examination consisting of 
the following:  measurement of visual acuity, Goldmann applanation tonometry, slit lamp 
examination of the anterior segment of the eye and dilated ophthalmic examination 
including evaluation of the crystalline lens using LOCS III classification. 
The cross-sectional study compared the structure of RNFL and function of RGCs using 
the following instruments:  i) confocal scanning laser ophthalmoscopy (HRT III, 
Heidelberg Engineering, software version 3.1.2), ii) interferometry (OCT Cirrus, Carl 
 61 
Zeiss Meditec, Dublin, CA, software version 3.0.0.64), iii) Scanning Laser Polarimetry 
(GDx VCC, Carl Zeiss Meditec, Dublin, CA, software version 6.0.0) iv) Flicker Defined 
Form, (Heidelberg Engineering, software version 2.0.1.12), v) Standard Automated 
Perimetry (SAP, Humphrey Field Analyzer, Carl Zeiss Meditec, software version 4.2), vi) 
Matrix (Carl Zeiss Meditec, software version M02.02.01), and vii) Moorfields Motion 
Displacement Test (Moorfields Eye Hospital, London).  Each instrument represents the 
current commercially available version for clinical use.  The purpose was to determine if 
a correlation exists between structure of the RNFL and function of RGCs in patients with 
and without glaucoma as measured with the instruments used in this study. 
 
All tests performed in Toronto were administered by one technician (CB).  Contour lines 
for HRT were drawn by the primary observer (CB).   
 
For the cross-sectional study, each subject attended 2 visits within a 16-week period.  At 
each visit one eye from each subject was examined with the three imaging techniques 
and four perimetry tests.  The order of image acquisition was not considered relevant as 
the techniques are not subjective.  The order of perimetry testing was randomized but 
remained constant for each patient; this was done to eliminate any bias that may be 
caused from the carryover effect.  Subjects were given at least 5 minutes to rest 
between tests in an attempt to eliminate the effect of fatigue on subsequent tests. 
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For the longitudinal study, glaucoma subjects from the Toronto site attended 2 
additional visits, approximately 12 weeks apart, at least 12 months after the last visit 
(Visit 2).  At the subsequent visits the same procedures as in Visits 1 and 2 were carried 
out.  Table 2.5 provides an overview of the techniques used at each of the visits.   
 
Table 2.5:  Techniques used for each visit. 
 Qualifying 
Exam 
HRT Cirrus 
OCT * 
GDx 
VCC* 
SAP FDT FDF MDT 
Visit 1       √ √ √ √ √ √ √ √ 
Visit 2   √ √ √ √ √ √ 
Visit 3     √ √ √ √ 
Visit 4     √ √ √ √ 
 
* Cirrus OCT and GDx VCC were only performed on the subjects from the Toronto site. 
 
 
2.5 Analysis 
 
All threshold estimates with a value less than 0 dB were given a value of 0 dB.  
 
Test-retest was tested with all function tests from all centers. 
 
Structure-function analysis with HRT and the four function techniques was done with 
subjects from all centers.  Structure-functional analysis of OCT and GDx was done only 
with the subjects from the Toronto site. 
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Progression between examinations for each of the four function tests was analyzed only 
for the glaucoma subjects from the Toronto site.   
 
The functional tests, SAP, FDT, FDT and MDT measure a total of 54, 55, 53 and 32 test 
locations, respectively.  The test grids for each of the techniques were superimposed 
and only those that overlapped with all four test grids were used.  Thus, a total of 32 
points were used that corresponded to the MDT test grid.  
 
 
 
 
 
Figure 2.1:  Overlapping Coordinates. Stimulus locations for the 24-2 algorithms for SAP, FDT, FDF and 
MDT.  For comparison purposes, the test grids from all techniques were superimposed and only the 32 
locations which were common to all four techniques was used; illustrated in grey (BS- blind spot).  The 
centers of overlapping points from all four test grids for each of the test point locations were less than 2o 
apart.   
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2.5.1 Test-retest 
 
Test-retest variability plots analyze the variability between tests.  This type of analysis 
can be a valid measure of variability only if no actual change has taken place, i.e. no 
progression of glaucoma.  Test-retest variability analysis shows, for the range of 
measurement values, the variability upon repeated measurement. 
 
Bland-Altman (Bland & Altman 1986) plots compare the average of two repeated 
measurements with their difference and they are used in method-comparison and 
validity studies in the medical literature.  The mean difference, and the 5th and 95th 
percent confidence limits of the difference are marked on the plots to define the range of 
differences in which 90% confidence interval into which the follow-up data fall.  Lower 
variability between measurements results in a narrower interval the technique is 
regarded more repeatable when compared to a test that has a wider confidence interval. 
 
The frequency of differences in threshold points between visits was calculated within 
each technique.  The frequency of data points was calculated globally and for threshold 
values in the range of near-normal, moderate to near-normal, severe to moderate and 
severe threshold values.  
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2.5.2 Structure-Function Correlation 
 
For the structure-function analysis, the maps created by (Garway-Heath et al. (2000) 
were used (Figure 2.2).  The points on the visual function tests were grouped according 
to the ONH sector they corresponded to.   
 
Figure 2.2:  Structure-function relationship of the 32 test locations tested with the 6 sectors of the optic 
nerve head based on the structure-function map of Garway-Heath et al (2000). Sectors 1, 2, 3, 4, 5, and 6 
represent the nasal, inferionasal, inferiotemporal, temporal, superiotemporal, and superionasal sectors, 
respectively. 
 
 
2.5.3 Progression 
 
Progression was determined between a visual function examination at Visit 1 or Visit 2 
and a corresponding examination at Visit 3 or Visit 4; the test that had better reliability 
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was used for analysis; if both tests had equal reliability, which was the fact in most 
cases, then the test to be analyzed was chosen at random.  Reliability was assessed 
using the reliability indices for each of the functional tests.  The time difference between 
Visit 2 and Visit 3 was approximately 1 year.  
 
Because each visual field instrument uses a different scale to measure threshold 
values, pattern deviation probability plots were used to compare progression.  Only 
probability levels of p>0.05, p<0.05 and p<0.02 were used, these were common 
between all devices and was limited to the probability levels used by the MDT.  Ordinal 
scores of 0, 2 and 5 were assigned to the p>0.05, p<0.05 and p<0.02 probability levels, 
respectively; this approach is similar to that used to weigh the Glaucoma Hemifield 
scores (Asman & Heijl 1992).  Scores from Visit 1/2 (relabeled as Visit A) and Visit 3/4 
(relabeled as Visit B) were compared to detect progression.   
 
The difference between ordinal scores for each point was calculated. 
Because only one set of follow-up data was available for this study, a point-by-point 
analysis was done and change was defined based on event-analysis. 
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3   Test-retest of Perimetry Tests in Early Glaucoma 
3.1 Overview 
Purpose:  To compare the test-retest characteristics of SAP, FDT, FDF and MDT to 
determine which is more suitable to measure visual field loss and potentially monitor its 
progression. 
Methods:  95 subjects with early glaucoma and 99 controls were enrolled in the study.  
Each subject attended 2 visits.  During each visit, one eye was examined with SAP, 
FDT, FDF and MDT.  Results from both visits were compared using paired Student’s t-
test, test-retest plots, frequency of difference plot, and Bland & Altman plots. 
Results:  Both SAP and MDT showed least variability in areas of near-normal sensitivity 
with increasing variability as sensitivity decreased.  FDT and FDF both showed constant 
variability throughout the dynamic range with FDF having a narrower 95% confidence 
interval.  
Conclusion: SAP is not able to detect abnormality as readily as FDT or FDF. However, 
SAP may be better at monitoring change in the near-normal range and FDF in the 
moderate to severe range of glaucoma.   
 
3.2 Introduction 
 
The purpose of a visual field examination in glaucoma is to detect defects and 
determine the specific pattern of visual field loss for diagnostic purposes, and monitor 
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patients for evidence of visual function defect progression (Chauhan et al. 1990; Spry et 
al. 2001; Spry & Johnson 2002). 
 
The current gold standard perimetry technique, SAP, has been shown to detect visual 
field defects after glaucoma has progressed to a moderate stage (Zeyen & Caprioli 
1993; C. Johnson 2009; Harwerth et al. 1999; Tuulonen et al. 1993; Chandra et al. 
2013; Jonas et al. 1989; Quigley et al. 1995; Hart et al. 1978; Sommer et al. 1979b). 
The development of new perimetry techniques have been aimed at selectively testing 
subsets of ganglion cells to better reflect ganglion cell loss (selective testing hypothesis) 
(Johnson 1994), test subsets of ganglion cells that may be more prone to glaucomatous 
damage (selective loss hypothesis) (Alward 2000), or test cognitive functions driven by 
selective input to the visual cortex that appear to be more prone to early disease 
(Swanson et al. 2004). 
 
Perimetry techniques such as Frequency Doubling Technology (FDT), Flicker Defined 
Form (FDF) and the Moorfields Motion Detection Test (MDT) are aimed at selectively 
testing the magnocellular pathway, and its cortical processing (Swanson et al., 2004) 
however, SAP has been shown to also test the function of M cells (Swanson, Sun, Lee 
& Cao 2011).   
 
The Heidelberg Edge Perimeter (HEP; Heidelberg Engineering, Germany) is a new 
perimetry instrument which uses both Standard Automated Perimetry and Flicker 
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Defined Form (FDF) (Ramchandran & Rogers-Ramchandaran 1991; Flanagan et al. 
1994), an illusionary stimulus. Flicker Defined Form stimulus is believed to 
predominantly stimulate RGCs of the magnocellular pathway because the illusion is not 
perceived using equiluminant chromatic stimuli and is resistant to blur (up to 6D) 
(Heidelberg Edge Perimeter 2010), thus it may be a good indicator for early glaucoma 
damage.   
 
Moorfields MDT is a new perimetric motion-displacement test designed to diagnose 
glaucoma in the early stages (Verdon-Roe et al. 2006) using stimuli generated on a 
laptop computer. The ability to detect motion is believed to diminish early in glaucoma 
(Silverman et al. 1990).  Hence, the MDT also has potential for early detection.  
Accurately detecting functional change is important to the management of glaucoma.   
The purpose of this study is to compare the test-retest characteristics of four measures 
of visual function to determine which is more suitable to measure visual field loss and 
potentially monitor its progression.  
 
In order to determine test-retest variability of the perimetry tests, comparisons were 
made using global indices and threshold estimates. 
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3.3  Methods 
 
The recruitment criterion was as described in Chapter 2 section 2.2.  The study sample 
demographics are shown in Table 2.2.  The procedures are explained in section 2.5. 
 
3.4 Analysis 
The patient’s age and severity of visual field, ONH and RENFL defect were considered 
as separate between-subject factors. 
 
Table 3.1 displays the mean and standard deviation for the visual field indices Mean 
Deviation (MD), Pattern Standard Deviation (PSD), and test duration; MDT does not 
calculate MD and PSD.  The Student’s t-Test was used to compare these indices from 
Visit 1 with Visit 2. 
 
 
Table 3.1:  Mean Deviation (MD), Pattern Standard Deviation (PSD) and Examination 
Duration. 
 
 
The Paired Student’s t-test was sued to compare sector averages between visits for  
 
each technique (Table 3.2). 
 
 
Index Visit SAP FDT FDF MDT 
MD 1 -1.62 + 3.36 -2.36 + 4.75 -5.03 + 5.29 --- 
 2 -1.49 + 3.44 -2.08 + 4.61 -4.56 + 5.36 --- 
PSD 1 2.89  + 2.54 3.42 + 1.49 3.39 + 1.56 --- 
 2 2.67 + 2.31 3.44 + 1.47 3.28 + 1.57 --- 
Examination Duration 1 5.14 + 0.77 5.14 + 0.38 5.23 + 1.42 6.65 + 0.92 
(minutes) 2 5.05 + 0.71 5.16 + 0.22 5.91 + 1.47 6.64 + 0.99 
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Table 3.2:  Paired Student’s t-Test p-values:  Visit 1 vs Visit 2. 
Technique S1 S2 S3 S4 S5 S6 MS 
SAP 0.394(N) 0.303(N) 0.211(N) 0.089(N) 0.308(N) 0.105(N) 0.478(N) 
FDT 0.834(N) 0.741(N) 0.481(N) 0.777(N) 0.593(N) 0.821(N) 0.778(N) 
FDF 0.154(N) 0.227(N) 0.020(N) 0.064(N) 0.027(N) 0.232(N) 0.094(N) 
MDT 0.757(N) 0.721(N) 0.215(N) 0.948(N) 0.206(N) 0.482(N) 0.031(N) 
Average of sectors and mean sensitivity (MS).   N=not reject H0. 
 
 
Test-retest variability for each technique was plotted as a function of visual field 
sensitivity or threshold for Visit 1 to Visit 2 (Figure 3.3).  The analysis describes the 5th 
and 95th confidence limits into which 90% of follow-up threshold estimates are likely to 
fall, provided no real change has occurred. 
 
 
 
 
Figure 3.1:  Test-retest plots showing the 95th, 50th and 5th percentiles for the distribution of retest 
sensitivity across the range of sensitivities measured, collapsed across all spatial locations for each 
technique.  The threshold sensitivity from Visit 2 for each given location is plotted with respect to the 
threshold sensitivity value of Visit 1 (i.e. within-algorithm, between-visit analysis).  The shaded 
areas denote the near- normal sensitivity range for each of the techniques. 
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The frequency of data points as a function of threshold difference between Visits 1 and 
2 was plotted to illustrate which perimetry technique had the most number of points with 
no difference and at what threshold difference most of the data points fall within.  Table 
3.3 summarizes the data from Figure 3.2.  The frequency of threshold estimates with 0 
difference between visits and the maximum threshold difference for 90% of the data for 
each of the techniques is provided.   
 
 
Figure 3.2:  Global frequency of difference for all threshold points between Visits 1 and 2. 
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Table 3.3:  Summary data from frequency of differences graphs. 
 
 
 
 
 
 
 
 
 
Bland & Altman (1996) plots comparing repeatability of threshold estimates are shown 
in Figure 3.3.  The mean, and +1.96 SD were noted on the graphs.  The data is 
summarized in Table 3.4.  This table includes the 90% confidence interval of the upper 
and lower limits of agreement as described by Carkeet (2015).   
 
 
 
 
 
 
 
Technique Test locations with 0 
dB/MinArc difference 
(%) 
Maximum threshold 
difference of 90% of 
data (dB/MinArc) 
SAP 22 4 
FDT 46 7 
FDF 21 8 
MDT 26 10 
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Figure 3.3:  Bland & Altman shows the sensitivity values with respect to stimulus sensitivity or threshold of 
Visit 1 and Visit 2 for each technique with mean and +1.96 standard deviations.  The differences between 
Visits 1 and 2 (Visit 1 – Visit 2) are plotted with respect to the average of the two sensitivity values.  The 
shaded areas denote the near-normal sensitivity range for each technique. 
 
 
 
 
 
Table 3.4:  Statistics from Bland & Altman Plots 
Technique MoD -1.96 SD 
(95% CL) 
+1.96 SD 
(95% CL) 
Limits of Agreement  
(90% CI) 
SAP 2.05 -3.05  
(-2.97, -4.09) 
7.60 
(7.04, 8.15) 
10.65 
FDT 2.84 -4.22 
(-3.60, -5.04) 
9.90 
(9.34, 10.78) 
14.12 
FDF 3.82 -4.14 
(-3.43, -5.04) 
11.79 
(11.08, 12.69) 
15.92 
MDT 3.93 -5.93 
(-5.08, -7.09) 
13.79 
(13.04, 15.05) 
19.72 
All values are in decibels (dB) except MDT which is in minutes of arc (MinArc).  
MoD = mean of differences, CI = confidence interval, CL= confidence limit. 
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3.5 Results 
 
Table 3.1 lists the global indices and test duration for each of the techniques studied.  
MDT was not included in the global indices comparison, as it does not calculate global 
indices.  No significant difference within test was found between Visit 1 and Visit 2 for 
any of the parameters (p>0.05) except for MDT being approximately 1 minute longer 
than the rest of the techniques.  Paired Student’s t-test (Table 3.2) for the average of 
each sector and mean sensitivity showed no significant difference between Visit 1 and 
Visit 2.  
Figure 3.1 displays the mean, 5% and 95% confidence limits for the range of values 
recorded in Visit 2 for a specific stimulus level in Visit 1.  The SAP technique showed 
least variability in areas of normal to near normal sensitivity with increasing variability as 
sensitivity decreased.  Moorfields MDT showed a similar trend to that of SAP but with 
greater variability throughout its dynamic range.  Both FDT and FDF showed consistent 
variability throughout the instruments’ dynamic range with FDT having a narrower range 
into which 90% of the follow-up data fall. 
 
Figures 3.2 plot the global frequency of data points as a function of dB difference 
between visits. FDT showed the greatest fraction of threshold locations with a 0 dB 
difference between visits; however, SAP showed the most number of points with the 
least difference, followed by FDT.  Moorfields MDT showed the greatest variability; this 
was in agreement with the test-retest plots. 
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Bland & Altman plots were calculated between visits for each technique (Figure 3.3); the 
average of two corresponding points was plotted against their difference (Visit 1 – Visit 
2).  The mean of differences and the Limits of Agreement (90% confidence intervals) 
are shown in Table 3.4.  The diamond pattern is observed as a result of the floor effect 
(Wall et al. 2010) where below a certain sensitivity value, 0dB is the most frequent value 
on retest.  This value is specific to each technique and defines the limit of the 
techniques dynamic range.  For example, if the values from the two visits span the 
entire dynamic range (i.e. 0 and 40), the difference and average of these values will be 
40 and 20, respectively.  As the average of the two values deviates from the median, 
the difference between the values starts to decline.  Thus, the further away the average 
of the two values is, the closer the difference will be to 0, giving rise to the diamond 
pattern.  The difference in distribution of points within each technique is due to its 
unique properties.  For both the FDT and FDF, variability is constant throughout the 
dynamic range that results in the fairly even distribution of points within the diamond 
pattern.  Due to its limited number of final threshold estimates, the data points of the 
FDT are more sparse.  In SAP, variability is less in the near-normal range, resulting in a 
narrow difference interval.  Both SAP and MDT also have more points in the near-
normal range explaining the higher density of points in this area.   
 
Both FDT and FDF showed an even distribution of variability throughout the dynamic 
range with FDF showing a narrower interval.  These results are in agreement with those 
seen with the test-retest plots. 
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3.6 Discussion 
 
In perimetry, test-retest variability is dependent upon the stage of visual field defect 
being studied (Heijl et al. 1989), the stimulus characteristics (Wall et al. 1997) and, the 
algorithm used to estimate the sensitivity (Bengtsson et al. 1997).  It has been 
previously noted that following disease progression in glaucoma is problematic as high 
levels of test-retest variability have been shown in moderate to severe stages of this 
disease (Chauhan & Johnson 1999;  a Heijl et al. 1989).  Thus, it is imperative to 
determine variability within a technique to determine whether or not it is suitable to 
measure visual field loss and monitor its progression.  Previous studies have shown that 
the Matrix has uniform test-retest variability across its dynamic range (Artes, Hutchison, 
et al. 2005); in comparison to SAP, repeatability is greater in the normal range but gets 
worse in advanced defect.  The FDF has also been shown to have uniform variability 
throughout its dynamic range; variability is similar to SAP in the normal range and 
improves in areas of increased defect (Heidelberg Engineering 2010).  The main 
objective of this study was to test repeatability and test-retest characteristics of SAP, 
FDT, FDF and MDT to determine which technique is better suited to detect early 
glaucoma and monitor its progression. 
 
The point-by-point analysis in Figure 3.1 describes the repeatability of each technique 
across the various sensitivity estimates. SAP and MDT variability increases as 
sensitivity decreases.  This is in agreement with several previously published studies on 
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SAP test-retest characteristics (Henson et al. 1997; Russell et al. 2012); test-retest 
variability in SAP has also been shown to increase with increasing defect depth and 
eccentricity (Weber & Rau 1992; Olsson et al. 1993; Chauhan et al. 1993; Henson et al. 
1997; Chauhan & Johnson 1999; Smith et al. 1996; Katz et al. 1997).  MDT showed a 
slightly greater variability; however, both FDT and FDF showed uniform variability 
throughout the instruments’ dynamic range with FDF having a narrower 90% confidence 
interval. This is also in agreement with previously published studies (Artes et al. 2005; 
Heidelberg Engineering 2010) where test-retest variability of FDT does not increase as 
much as SAP with an increase in defect severity (Spry et al. 2001).  SAP has shown to 
be a poor diagnostic test for patients with early glaucoma, however, its performance 
improves (Spry et al. 2003) and variability increases (Harwerth et al. 2002; Weber & 
Rau 1992; Olsson et al. 1993; Wall et al. 1997; Chauhan et al. 1993; Henson et al. 
1997) as sensitivity is reduced.   
 
Frequencies of dB differences between visits are shown in Figure 3.2. FDT showed the 
highest fraction of 0 dB difference, which can be attributed to the fact that FDT has a 
smaller number of final threshold estimates compared to the other techniques (i.e. 15 vs 
29 or 39).  All techniques showed increasing variability with increasing disease severity 
with FDF having the least difference between threshold values from Visit 1 and Visit 2.  
 
The Bland-Altman plots (Figure 3.3) showed greatest test-retest variability in the 
moderate defect range with all techniques; MDT was calculated to have the greatest 
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limits of agreement and mean of differences.  SAP had the smallest values in both these 
parameters followed by FDT and FDF.  The distribution described by the Bland-Altman 
plots (Figure 3.3) is in agreement with the trends seen in test-retest plots (Figure 3.1).  
In patients with open angle glaucoma, threshold values can vary as much as 10 dB and 
21 dB, at locations with normal and moderate initial threshold values, respectively 
(Chauhan & Johnson 1999; Heijl et al. 1989; Holmin & Krakau 1979; Werner et al. 1982; 
Wilensky & Joondeph 1984; Katz & Sommer 1986; Lewis et al. 1986).  In some cases, 
test-retest variability can span the entire dynamic range (Heijl et al. 1989) which makes 
it difficult to distinguish variability from true change (Haymes et al. 2005; Artes, 
Hutchison, et al. 2005).  
 
The trends seen with the various techniques in this study indicates that SAP may be 
better at monitoring change in the near-normal range and FDF may be better for 
monitoring change in the moderate to severe range of glaucoma.  However, the fact that 
more abnormal points are seen with FDT and FDF in comparison to SAP, as suggested 
by the MD and PSD calculations in Table 3.1, is evidence that SAP may not able to 
detect abnormality as readily as FDT and or FDF.  This is in agreement with previous 
studies comparing the dynamic range of various perimetric techniques (Wall et al. 
2010).  FDF has been shown to detect glaucomatous damage when no defect was 
detected by SAP (Horn et al. 2016; Hasler & Stürmer 2012; Reznicek et al. 2015).  
However, SAP may be a suitable technique for monitoring progression in the moderate 
to late stages of glaucoma.   
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Early detection of glaucomatous damage and its progression over time is one of the 
most important clinical challenges in glaucoma (Hood & Kardon 2007).  Thus, it is 
crucial to have tests that not only detect defect but also are repeatable in order to show 
true progression.  A major limitation of this study was the fact that each technique has a 
unique threshold scale onto which its sensitivity values are calculated. 
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4   Structure-function relationship between Heidelberg Retina Tomograph 
with SAP, FDT, FDF and MDT 
 
4.1 Overview 
Purpose:  The purpose of this study was to determine which perimetry technique best 
correlates with the structure of the ONH, both global and sectoral, as measured by the 
HRT.  
Methods:  70 patients with early glaucoma and 87 controls were enrolled in the study.  
Each subject attended 1 visit during which one eye was measured with HRT and visual 
function was determined using SAP, FDT, FDF and MDT.  In order to determine 
agreement between HRT and the perimetry tests, comparisons were made using 
sectoral and global analysis of the ONH sectors.  Venn diagrams were used to show the 
diagnostic overlap amongst the HRT and 4 perimetry tests.  Concordance charts were 
used to show the global and sectoral diagnostic overlap of the perimetry tests with that 
of the HRT.  
Results:  More agreement is seen with perimetry tests and the HRT when global 
classification of the ONH by HRT is outside normal limits.  Sectorally, FDF showed 
greatest agreement with HRT when the sector was classified as outside normal limits 
and least agreement when the sector was classified as WNL.  Sensitivities of 60.0, 60.0, 
87.1 and 62.8 and specificities of 73.6, 75.9, 54.0 and 69.0 were calculated for SAP, 
FDT, FDF and MDT, respectively. 
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Conclusion:  The poor diagnostic agreement seen between the HRT and each 
perimetry test may be due to the fact that each technique is identifying a different 
characteristic of glaucomatous damage. Because no one perimetry test has both high 
sensitivity and high specificity, it is recommended that a combination of FDF with either 
SAP, FDT or MDT be used as the functional component in the diagnosis and follow-up 
of patients with glaucoma.  
 
4.2 Introduction 
Understanding the structure-function relationship in glaucoma is necessary for 
understanding the natural history of the condition and grading of its severity (Malik et al. 
2012b). Defining the structure-function relationship in glaucoma is currently the topic of 
ongoing research; considerable variation exists between the structure-function 
relationships in glaucoma (Ventura et al. 2006).  
Imaging of the ONH and RNFL by computerized methods has become common practice 
in the detection and management of glaucoma in addition to the field tests (Breusegem 
et al. 2011; Greenfield 2002). 
Confocal SLO provides accurate topographic maps of the optic disc and peripapillary 
retina and provides objective and reproducible data for analysis (Burgoyne 2004; 
Mikelberg et al. 1993; Rohrschneider et al. 1994) and discrimination between patients 
with and without glaucoma (Chauhan et al. 1994; Bathija et al. 1998; Mikelberg et al. 
1995).  
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The purpose of this study was to determine which perimetry instruments best correlate 
with the structure of the optic nerve, both globally and sectorally, as measured by the 
HRT.  For the purposes of this study, the Moorfields Regression Analysis computed by 
the HRT and IOP measurements defined the presence or absence of glaucoma.   
 
4.3 Methods 
 
The recruitment criterion was as described in Chapter 2 in section 2.2.  The study 
sample demographics are listed in Table 2.3.  The procedures are explained in section 
2.5. 
 
In order to determine agreement between HRT parameters and perimetry tests, 
comparisons were made using sectoral and global analysis of the HRT as described in 
Figure 2.2.   
 
 
4.4 Analysis 
 
 
Visual field sectors and entire visual fields were classified as within normal limits (WNL), 
or outside normal limits (ONL) based on the criteria listed in Table 4.1.  Venn diagrams 
of overlapping agreement between visual field tests were made.  This was stratified on 
the basis of the global classification of HRT being WNL or ONL. 
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Table 4.1:  Visual field classification criteria. 
Classification Sector Entire Field 
WNL < 30% of points at p<0.05 < 1 sector ONL 
ONL > 30% of points at p<0.05  
OR  
>1 point at p<0.02 
> 1 sectors ONL 
WNL- within normal limits, ONL – outside normal limits 
 
 
 
 
 
Diagnostic overlap between HRT and function specific perimetry were illustrated using 
pie charts.  Figure 4.1 displays global comparison while figure 4.2 compares the 
diagnosis by sector. 
 
Table 4.2:  Sensitivity, specificity, Positive and Negative Predictive Values from global concordance and 
discordance. 
 
 SAP FDT FDF MDT 
Sensitivity 60.0 60.0 87.1 62.8 
Specificity 73.6 75.9 54.0 69.0 
Positive Predictive Value 70.0 70.2 83.9 70.0 
Negative Predictive Value 64.6 66.7 60.4 62.0 
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Figure 4.1: Global concordance and discordance between HRT and perimetry. 
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Figure 4.2:  Illustration of the concordance and discordance between HRT and each visual field by sector. 
 
Venn diagrams were constructed to show the diagnostic overlap of the four perimetry 
techniques to the HRT classifications of WNL and ONL (Figure 4.3).   
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Figure 4.3:  Venn diagram showing global diagnostic overlap of perimetry tests for subjects classified as 
WNL and ONL with respect to the ONH and IOP as classified by HRT and Goldmann applanation 
tonometry, respectively.  The number in brackets beneath the perimetry technique indicates the number 
of subjects whose visual field was classified as ONL by that technique. The circles on the top represent 
the number of subjects in whom all 4 perimetry tests are WNL. 
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Figure 4.4:  Illustration of the percentage of agreement between ONH and visual field test with respect to 
each sector.  The numbers in bold highlight the sector with the greatest agreement within each perimetry 
technique. 
 
 
 
4.5 Results 
 
 
Concordance and discordance of the visual function tests to that of the HRT are shown 
globally and sectorally in Figure 4.1 and 4.2, respectively.  Figure 4.3 are Venn diagram 
displaying the overlap of glaucoma classification of the perimetry techniques with 
respect to the classification of the HRT.  All four perimetry techniques show more 
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agreement with the HRT when the eye was classified as glaucomatous as opposed to 
normal by HRT and IOP measurements.  In both categories SAP, FDT and MDT 
showed similar agreement with the HRT; FDF showed greatest agreement when HRT 
classified the ONH as ONL and least agreement when the ONH was classified as WNL.  
 
Figure 4.1 illustrates the diagnostic overlap between HRT and the perimetry techniques.  
In patients who were classified as WNL with respect to the HRT, there was 
approximately 70% agreement with SAP, FDT and MDT but only 54% agreement with 
FDF.  In subjects classified as ONL with respect to HRT, agreement was seen with 87% 
of FDF data and approximately 40% with SAP, FDT and MDT.  Concordance and 
discordance charts of HRT with VF tests also show FDF to be in greatest agreement 
with HRT when the ONH is classified as ONL and least agreement when ONH is 
classified as WNL.  FDF also classifies more visual field tests as ONL than any of the 
three functional techniques irrespective of HRT classification.   
 
Globally, calculations of sensitivity and specificity amongst the perimetry instruments 
were in the same range except for FDF, which showed a significantly higher sensitivity 
and lower specificity (Table 4.2).  Positive and negative predictive values showed a 
similar trend with FDF having the highest and lowest positive and negative predictive 
values, respectively.    
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Overall there was similar ratio of agreement to disagreement in all perimetry tests.  
However, when looking at the distribution more closely, FDF shows greater agreement 
with HRT when the ONH sector is classified as glaucomatous and less agreement when 
the ONH is classified as normal.  
 
Figure 4.4 displays the percentage of agreement between ONH and perimetry tests with 
respect to each sector.  ANOVA calculations both within each perimetry test and within 
each sector were done to determine if any significant difference exists amongst the 
sectors and perimetry tests, respectively.  A p-value of 0.789 was calculated for 
between test-within sector and a p-value of 0.001 for between sector-within test (α= 
0.05).  Thus, there is a significant difference amongst the sectors with respect to each 
perimetry test, but there is no significant difference with respect to the perimetry tests 
within each sector.  SAP showed greatest agreement in the temporal sector, FDT in the 
superiotemporal sector, and both FDF and MDT in the inferiotemporal sector. 
 
4.6 Discussion 
Clinically, the diagnosis of glaucoma involves correlating structural changes with 
functional deficits.  Strong evidence suggests that glaucoma can progress to a 
moderate a stage before a visual field defect is seen on SAP (Johnson 2009; Harwerth 
et al. 1999; Zeyen & Caprioli 1993; Quigley et al. 1992; Tuulonen et al. 1993; Chandra 
et al. 2013; Hart et al. 1978; Sommer et al. 1979a) and structural changes are present 
before any visual field damage is detected by SAP (Kuang et al. 2015; Quigley et al. 
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1992; Chandra et al. 2013; Wilensky & Kolker 1976; Leung et al. 2005; Kanamori et al. 
2008; Reus et al. 2006; Bowd et al. 2006a).  The main objective of this study was to 
determine which perimetry technique showed the greatest agreement with structure of 
the ONH, both globally and sectorally, as measured and classified by the HRT and 
Goldmann applanation tonometry.   
 
Previous studies have shown that HRT parameters are a good indicator of 
glaucomatous ONH damage (Iester et al. 1997) as it has shown to acquire repeatable 
and reliable measurements of the ONH (Mikelberg et al. 1993; Rohrschneider et al. 
1994; Chauhan et al. 1994), provide reasonable levels of sensitivity and specificity 
(Mikelberg et al. 1995; Bathija et al. 1998; Uchida et al. 1996; Zangwill et al. 2007) and 
be in agreement with clinical examination (Yaghoubi et al. 2015).  HRT parameters such 
as rim area, rim volume and mean RNFL height have been shown to be well correlated 
with mean deviation and corrected pattern standard deviation of SAP tests (Brigatti & 
Caprioli 1995; Iester, Mikelberg, et al. 1997; Iester, Swindale, et al. 1997; Tole et al. 
1998).  For these reasons and the purpose of this study, HRT was chosen as the gold 
standard for classification of the eyes.   
 
Figure 4.3 displays Venn diagrams showing the global diagnostic overlap between HRT 
and the functional tests.  It should be kept in mind that the structure-function relationship 
in glaucoma is not clear as it relies on several factors including physiological variation 
amongst individuals (Pan & Swanson 2006) age (Ren et al. 2014; Honjo et al. 2015) 
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and the stage of the disease (Harwerth et al. 2005).  Studies have shown either 
parameter can change before the other or simultaneously (Kass et al. 2002; Heijl et al. 
2002; Malik et al. 2012a).  Even with the use of advanced diagnostic and analytic 
procedures, correlation between structural and functional changes in glaucoma can be 
seen in less than 50% of the cases (Drance 1985; Turpin et al. 2009; Gardiner et al. 
2005; Garway-Heath, Caprioli, et al. 2000; Strouthidis, Vinciotti, et al. 2006).  This 
explains why some subjects who were diagnosed as WNL with respect to the HRT 
showed functional defect on up to 4 perimetry techniques.   
 
The sensitivity and specificity values calculated for global concordance and discordance 
were similar for SAP, FDT and MDT; FDT showed greater sensitivity but less specificity.  
The sensitivity and specificity values were expected to be similar for all perimetry 
techniques as they are all capable of preferentially stimulating M cells before P cells 
(Swanson et al. 2011).  However, the fact that FDF has greater sensitivity indicates that 
it has the potential to identify glaucoma earlier than the other perimetry tests, making it a 
more suitable screening test for glaucoma.  Sensitivity and specificity of diagnostic 
instruments may not be applicable to all subgroups of patients with the disease in 
question (Ransohoff & Feinstein 1978).  Hence, diagnostic tests are more sensitive in 
advanced stages of disease and its diagnostic accuracy may not be applicable to 
patients in the early stages or those who are suspects (Lachs et al. 1992; Moons et al. 
1997).  Because no one perimetry test has both high sensitivity and high specificity in 
the findings of this study, it is recommended that a combination of FDF with either SAP, 
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FDT or MDT be used as the functional component in the diagnosis and follow-up of 
patients with glaucoma.  Similar agreement was seen when individual sectors were 
compared.  
 
Sectoral agreement with respect to each perimetry test showed SAP to have the most 
agreement in the temporal sector.  The temporal region of the ONH is the last and the 
least sector of the ONH to show glaucomatous damage would have the greatest 
number of sectors classified as WNL.  The inferior ONH sector is most likely the first 
sector to show structural change thus, it is expected that function tests designed to 
detect glaucomatous damage early would show the greatest agreement in this region.  
This was seen with both FDF and MDT, specifically in the inferiotemporal sector 
however, FDT showed its greatest agreement in the superiotemporal sector. 
 
Ideally, in order to determine which parameter, structure or function, better detects 
glaucomatous damage first, there needs to be an alternate parameter that will be the 
gold standard for glaucoma diagnosis.  In this case, we are limited by the fact that no 
such parameter exists and this should be kept in mind when comparing structure and 
function measures in glaucoma. 
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5 Structure and Function Relationships in Glaucoma using OCT, GDx VCC 
with Standard and Function Specific Perimetry 
 
5.1 Overview 
 
Purpose: To evaluate the structure-function relationship between measures of RNFL 
and visual function; specifically to determine whether or not visual function corresponds 
to structure and which instruments best correlate structure and function of the ONH and 
RNFL.   
Methods:  38 subjects with early glaucoma had RNFL thickness measured with OCT 
and GDx and RNFL function measured with SAP, FDT, FDF and MDT during one visit.  
The data was recalculated to fit the 6 sectors of the ONH as divided by the HRT in order 
to have a common ground for comparing the measurements.  Comparisons of RNFL 
thickness as measured by OCT and GDx were made using regression analysis.  Both 
linear and logarithmic associations were made with OCT and GDx with each of the 
perimetry techniques. 
Results:  Both OCT and GDx showed the classic double-hump pattern as expected 
with the normal anatomy of the RNFL, with OCT detecting thickness to be 
approximately 1.5 times thicker in all sectors as compared to GDx.  Logarithmic 
associations were stronger than that of linear associations for all function tests in both 
OCT and GDx comparisons.  Associations with visual field sensitivity were stronger for 
OCT than GDx, except for FDF.  
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Conclusion:  The difference in strength of association as seen with the two structural 
imaging techniques confirms that each technique is measuring a different parameter of 
the RNFL and cannot be used interchangeably.  The strongest global structure-function 
correlations for OCT were seen with SAP, FDT and MDT; for GDx, the strongest 
association was seen with FDF.  The result of this preliminary study suggests that FDF 
and GDx used in combination are best to detect early glaucomatous changes.  
 
5.2 Introduction 
 
Defining the relationship between structural and functional loss in glaucoma has been of 
great interest since the 1850s (Drance 1974).  Several studies have shown that 
glaucomatous defects in RNFL usually occur before defects are seen on SAP 
(Airaksinen & Heijl 1983; Airaksinen & Drance 1985; Lan et al. 2003) particably, leading 
to the conclusion that measurement of structural changes to the ONH, and RNFL offers 
the prospect of improved early detection and monitoring of glaucoma (Quigley 1986; 
Drance 1985; Bowd et al. 2001).  Various imaging techniques such as optical coherence 
tomography (OCT) (Schuman et al. 1995; Schuman et al. 1996), confocal scanning 
laser ophthalmoscopy (CSLO) (Strouthidis & Garway-Heath 2008; Fechtner et al. 1993; 
Uchida et al. 1996; Zangwill et al. 1996; Lemij & Reus 2008) and scanning laser 
polarimetry (SLP) (Zeimer et al. 1998; Medeiros et al. 2004) use different properties of 
light to quantitatively assess topography and other structural properties of the ONH and 
RNFL (Ventura et al. 2006; Weinreb et al. 1990; Weinreb et al. 1993; Weinreb 1999; 
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Huang et al. 1991; Hoh et al. 2000; Greenfield 2002; Kotera et al. 2008; Zangwill et al. 
2000; Niessen et al. 1996; Chang & Budenz 2008).  
 
The purpose of a visual field examination in glaucoma is to detect defects and 
determine the specific pattern of visual field loss for diagnostic purposes, and monitor 
patients for evidence of visual function defect progression (Chauhan et al. 1990; Spry et 
al. 2001; Spry & Johnson 2002).  Standard automated perimetry (SAP) is currently the 
gold standard for detecting glaucomatous visual field loss (Quigley 1993; Sommer et al. 
1991; Johnson 1996; Bayer & Erb 2002; Anderson 1987; Alexander 1991; Johnson & 
Sample 2003; Sekhar et al. 2000).  
 
The development of second generation visual function techniques has been aimed at 
selectively testing subsets of ganglion cells that may be more prone to glaucomatous 
damage (selective loss hypothesis) (Alward 2000) or test cognitive functions driven by 
selective input to the visual cortex that appear to be more prone to early disease. 
The use of perimetric tests which utilize flicker (Johnson 2009; Harwerth et al. 1999; 
Tyler 1981; Lachenmayer et al. 1989; Horn et al. 1997) and motion (Silverman et al. 
1990; Wall & Ketoff 1995; Bosworth et al. 1997) have been proposed for the early 
detection of glaucoma.  Visual function techniques such as Frequency Doubling 
Technology (FDT), Flicker Defined Form (FDF) and Moorfields Motion Detection Test 
(MDT) are aimed at selectively testing ganglion cells of the magnocellular pathway, and 
its cortical processing (Swanson et al. 2004).  
 97 
5.2.1 Structural Instruments 
 
5.2.1.1 Optical Coherence Tomography  
 
The Optical Coherence Tomography (OCT) is a non-invasive imaging technique which 
allows for quantitative examination of the optic disc and retina (Guedes et al. 2003) to 
evaluate ONH topography and macular thickness for diagnosis (Schuman et al. 1995a; 
Schumano et al. 1995b) and follow-up of patients with glaucoma (Medeiros et al. 2005). 
 A good correlation is demonstrated between OCT NFL measurements and histology of 
the retina (Toth 1997).  Visual field defects as measured by SAP have also been shown 
to correlate with RNFL measurements as measured by OCT in glaucomatous 
neuropathy (Harwerth et al. 2007). 
 
Measurement of RNFL thickness by OCT has been shown to be useful in the early 
detection of RNFL damage, as it has been shown to qualitatively differentiate RNFL 
thickness in normal and glaucomatous eyes (Liu et al. 2001), and may be a useful tool 
in monitoring glaucomatous changes (Kanamori et al. 2003).  
 
5.2.2 Scanning Laser Polarimetry 
 
Scanning laser provides a good and objective method for RNFL thickness evaluation 
(Chen et al. 2009) and has helped improve glaucoma detection (Zhou & Weinreb 2002; 
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Weinreb et al. 2003; Greenfield et al. 2003; Medeiros et al. 2003; Greenfield et al. 2002; 
Choplin et al. 2003) as it has shown a good correlation with histological measurements 
(Blumenthal et al. 2009; Cohen et al. 2008).   
 
The purpose of this study is to evaluate the structure-function relationship between 
measures of RNFL and visual function; specifically to determine whether or not visual 
function corresponds to structure and which instruments best correlate structure and 
function of the ONH and RNFL.  The specific aims of this study were to: i) determine the 
relationship between RNFL measures of OCT and GDx, ii) determine whether or not 
visual function corresponds to RNFL structure, and iii) determine the level of agreement 
between structure and function of the ONH and RNFL. 
 
5.3 Methods 
 
The recruitment criterion was as described in Chapter 2 section.  The study sample 
demographics are listed in Table 2.3.  The procedures are explained in section 2.5. 38 
subjects with early glaucoma were recruited for this preliminary study. 
 
5.4 Analysis 
In order to compare the data from the OCT, GDx and perimetry tests, the data from 
each instrument was recalculated to fit the 6-sector map of the HRT.  Comparison 
amongst the instruments were based on these sectors.  
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Figure 5.1 gives a schematic diagram showing overlapping sectors from GDx and OCT 
with that of HRT.  The 64 and 12 sectors from GDx and OCT, respectively, were 
calculated to fit the 6-sector map of the HRT.  The values were averaged to give a 
sectoral value which corresponds with that of the HRT sector.  These values were used 
to make comparisons between the structural tests and between structural and functional 
measurements from each instrument.   
 
Figure 5.1:  Schematic diagram showing overlapping sectors from GDx and OCT with 
that of HRT.  The 64 and 12 sectors from GDX and OCT, respectively, were calculated 
to fit the 6-sector map of the HRT.  The values were averaged to give a sectoral value 
which corresponds with that of the HRT sector. 
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All threshold estimates with a value less than 0 dB were given a value of 0 dB; at 
locations with two threshold estimates the average value was used.  
Correlations between RNFL thickness measurements of OCT and GDx were performed 
using sectoral and global values.  Figure 5.4 represents the linear regression of average 
thickness of OCT and GDx values as depicted by each of the 6 sectors.  Correlations 
between structural instruments and the four visual function techniques were compared 
using both linear (y=a+bx) and logarithmic (y=a+b.In(x)) associations (because visual 
field sensitivity is measured in logarithmic units, dB).  The student’s t-test was used to 
test the statistical significance of r.    
 
5.5 Results 
 
Figure 5.2 shows a scatterplot of the linear regression of RNFL thickness as measured 
by OCT and GDx with respect to each sector for each patient.  Global and sectoral 
correlation coefficients of RNFL thickness between these two structural measures are 
listed in Table 5.1.  Correlation ranged from 0.28 (temporal sector) to 0.71 (superionasal 
sector); all correlations were statistically significant.  Measurement variability of both 
instruments increased in the same sectoral order: inferionasal, superiotemporal, 
superionasal, inferiotemporal, nasal and temporal. 
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Retinal thickness profiles as measured by the OCT and GDx are shown in Figure 5.3.  
Both OCT and GDx showed the classic double-hump pattern as expected with the 
normal anatomy of the RNFL, however OCT gives a thicker measurement in all sectors.   
 
 
 
Figure 5.2:  Scatterplot and linear regression line of RNFL thickness as measured by OCT and GDx VCC 
with respect to each of the six sectors.   
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Table 5.1:  Global and sectoral correlation coefficient of RNFL thickness with OCT and GDx. 
  RNFL Thickness (ave + SD)   
Sector  OCT GDx CC (r) p-value 
Global Global 88.93 + 21.62 59.15 + 15.52 0.66 <0.01 
1 Nasal 80.95 + 25.78 53.22 + 18.68 0.63 <0.01 
2 Inferionasal 65.28 +10.22 41.51 + 8.71 0.60 <0.01 
3 Inferiotemporal 85.93 + 24.47 68.57 + 17.67 0.41 <0.01 
4 Temporal 94.45 + 28.52 57.55 + 19.08 0.28 <0.05 
5 Superiotemporal 55.05 + 10.49 34.38 + 10.56 0.60 <0.01 
6 Superionasal 96.01 + 23.09 58.13 + 14.43 0.71 <0.01 
 
 
 
 
Figure 5.3:  RNFL thickness profile as measured by OCT and GDx from Visit 1. 
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comparing linear and logarithmic regressions is essential to detect and confirm the 
structure-function relationship and select the appropriate monitoring strategy to detect 
the change (Leung et al. 2005).  R2 values are shown in Tables 5.2 and 5.3 for GDx and 
Tables 5.4, 5.5, for OCT.  Logarithmic associations were stronger than that of linear 
associations for all function tests in both OCT and GDx comparisons.  Overall, both 
global linear and logarithmic associations with visual field sensitivity were stronger for 
OCT than GDx, except for FDF.  OCT showed the strongest association in the 
inferiotemporal RNFL sector with all visual field techniques whereas with the GDx, the 
strongest associations were seen in the superiotemporal sector with SAP, FDT and 
MDT and the superionasal sector for FDT.  
 
 
Table 5.2:  Linear (r2) association of GDx with Visual Function Tests. 
GDx SAP FDT FDF MDT 
 r2 p-value r2 p-value r2 p-value r2 p-value 
Global 0.18  0.01 0.21  <0.01 0.38  <0.01 0.17 0.01 
N 0.11  0.04 0.22 <0.01 0.20 <0.01 0.02 0.37 
IN 0.14  0.02 0.24 <0.01 0.37 <0.01 0.21 <0.01 
IT 0.12  0.03 0.10 0.06 0.19 <0.01 0.09 0.07 
T 0.01  0.63 <0.00 0.86 0.03 0.34 0.02 0.34 
ST 0.27 <0.01 0.29 <0.01 0.33 <0.01 0.27 <0.01 
SN 0.04  0.23 0.17 0.01 0.48 <0.01 0.02 0.34 
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Table 5.3: Logarithmic (r2) association of GDx with Visual Function Tests. 
GDx SAP FDT FDF MDT 
 r2 p-value r2 p-value r2 p-value r2 p-value 
Global 0.21 <0.01 0.25  <0.01 0.41  <0.01 0.19 <0.01 
N 0.12 0.03 0.23 <0.01 0.20 <0.01 0.02 0.37 
IN 0.13 0.3 0.23 <0.01 0.36 <0.01 0.19 <0.01 
IT 0.18 <0.01 0.13 0.03 0.26 <0.01 0.13 0.03 
T <0.00 0.68 <0.00 0.86 0.03 0.31 0.03 0.34 
ST 0.34 <0.01 0.30 <0.01 0.34 <0.01 0.32 <0.01 
SN 0.04 0.25 0.16 0.01 0.50 <0.01 0.02 0.34 
          
 
Table 5.4:  Linear (r2) associations of OCT with Visual Function Tests. 
OCT SAP FDT FDF MDT 
 r2 p-value r2 p-value r2 p-value r2 p-value 
Global 0.27 <0.01 0.35  <0.01 0.33  <0.01 0.19 <0.01 
N 0.03 0.31 0.09 0.07 0.12 0.04 0.03 0.28 
IN 0.16 0.13 0.24 <0.01 0.22 <0.01 0.21 <0.01 
IT 0.40 <0.01 0.47 <0.01 0.46 <0.01 0.39 <0.01 
T 0.11 0.04 0.18 <0.01 0.14 0.02 0.07 0.11 
ST 0.34 <0.01 0.35 <0.01 0.33 <0.01 0.18 <0.01 
SN 0.06 0.15 0.16 0.01 0.22 <0.01 <0.01 0.90 
           
Table 5.5:  Logarithmic (r2) associations of OCT and Visual Function Tests. 
OCT SAP FDT FDF MDT 
 r2 p-value r2 p-value r2 p-value r2 p-value 
Global 0.30 <0.01 0.40  <0.01 0.35  <0.01 0.22 <0.01 
N 0.04 0.25 0.09 0.06 0.14 0.02 0.04 0.23 
IN 0.19 <0.01 0.29 <0.01 0.24 <0.01 0.26 <0.01 
IT 0.46 <0.01 0.54 <0.01 0.47 <0.01 0.47 <0.01 
T 0.13 0.03 0.18 <0.01 0.14 0.02 0.08 0.08 
ST 0.41 <0.01 0.40 <0.01 0.36 <0.01 0.23 <0.01 
SN 0.08 0.09 0.20 <0.01 0.25 <0.01 <0.01 0.68 
          
 
5.6 Discussion 
 
Early detection of glaucomatous damage and its progression over time is one of the 
most important clinical challenges in glaucoma (Hood & Kardon 2007).  Detection and 
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management of glaucoma is two-fold:  i) observation and documentation of ONH and 
RNFL and, ii) measurement of visual function with automated perimeters.  Several 
patterns of glaucomatous RNFL and optic disc damage have been described 
(Airaksinen & Tuulonen 1984; Drance et al. 1986; Caprioli et al. 1987; Caprioli 1989; 
Tuulonen & Airaksinen 1991; King et al. 2000) and correlated with different patterns of 
visual field loss (Caprioli et al. 1987; Jost B. Jonas et al. 1988; Bowd et al. 2001).  It is 
therefore important to determine which techniques can accurately diagnose glaucoma 
and detect its progression both structurally and functionally throughout the course of the 
disease.  For the purposes of this study, we wanted to determine which structural and 
functional instruments showed the strongest correlations in patients with glaucoma.  
Previous studies have shown significant associations between HRT II, Stratus OCT and 
GDx VCC with standard automated perimetry (Bowd et al. 2006a). 
 
Correlations of OCT and GDx in this study showed a linear association between the two 
instruments.  This was seen in previous studies comparing the measurements of these 
two instruments in pre-perimetric glaucoma (Kim et al. 2011).  The total average RNFL 
thickness of the OCT is approximately 1.5 times that of the GDx despite the fact that the 
GDx measures RNFL closer to the optic disc than OCT.  This same trend was seen in 
other studies comparing the two instruments (Kim et al. 2011; Leung et al. 2005).  A 
difference in RNFL thickness was expected to be higher with OCT than that of GDx due 
to the difference in RNFL calculation by each instrument.  OCT calculates RNFL 
thickness by measuring the difference in differential reflectivity signals between the 
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vitreoretinal interface and the posterior border of the RNFL (Schuman et al. 1995) 
whereas GDx measure the retardation of polarized light from the RNFL axons and 
converts it into a thickness value (Weinreb et al. 1995). 
 
Looking at the sectoral correlations of this study (Table 5.1) both OCT and GDx showed 
the same sectoral order of increasing standard deviation in the order of inferionasal, 
superiotemporal, superionasal, inferiotemporal, nasal and temporal indicating that the 
greatest variability is seen in the nasal and temporal sectors of the peripapillary retina.  
Thinning of the neural rim at the superior and inferior poles has been shown to be the 
most reliable indicator of visual field defects (Goldberg 1981; Hoskins Jr & Gelber 1975; 
Gloster 1978; Hitchings & Anderson 1983).  Thus, both OCT and GDx are capable of 
detecting RNFL damage in early glaucoma, especially in the superior and inferior 
sectors however, their results are not interchangeable and progressive change should 
be monitored with only one instrument. 
 
Several previously published papers have compared visual field sensitivity, measured 
by SAP, to RNFL as measured by OCT and/or GDx.  Significant correlations have been 
seen between visual field sensitivity and peripapillary nerve fiber layer thickness as 
measured with OCT (Leung et al. 2005; Kanamori et al. 2008; Wollstein et al. 2005) and 
SLP (Reus & Lemij 2004b; Reus et al. 2006; Bowd et al. 2006a; Mai et al. 2007; 
Kanamori et al. 2008; Bowd et al. 2007; Choi et al. 2008).  A study by Aptel et al (2010) 
looked at the association of Cirrus OCT and GDx VCC in comparison to SAP; they also 
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found stronger structure-function associations with OCT than GDx when comparing to 
SAP.  In the current study, r2 values for log SAP, FDT, FDF and MDT for comparison 
with log OCT were 0.30, 0.49, 0.35 and 0.22, respectively; for comparison with GDx, the 
r2 values were 0.21, 0.25, 0.41 and 0.19, respectively.  Thus, the stronger global 
structure-function correlations for OCT were seen with SAP, FDT and MDT; for GDx, the 
stronger association was seen with FDF.  This could be due to the fact that RNFL 
thickness as measured but the GDx is based on the birefringence of both RNFL axons 
and organelles from supporting structures.  Thus, changes such as partial loss of 
supporting cell organelles or shrinkage of ganglion cells may alter the total birefringence 
of the RNFL before irreversible loss of axons occurs (Weber et al. 1998; Shou et al. 
2003).  Hence, changes in birefringence would be noted earlier than changes of axonal 
number.  With this concept and the results from chapters 3 and 4 of this thesis which 
showed that FDF can detect damage earlier than the other perimetry techniques, it is 
not surprising that FDF showed stronger association with GDx whereas SAP, FDT and 
MDT were more strongly associated with OCT.   
 
Sectorally, OCT showed the strongest association in the inferiotemporal RNFL sector 
with respect to all 4 visual field techniques.  GDx showed greater association between 
superiotemporal RNFL and its corresponding visual field sector with respect to SAP, 
FDT and MDT; with FDF, the greatest association was seen in the superionasal sector.  
This analysis may be of limited value as the number of perimetric test locations that 
contribute to each ONH sector are quite different (Figure 2.2). 
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The absence of a perfect correlation between optic disc and visual field defects 
indicates that both structure and function measurements are essential in the diagnosis 
and management of glaucoma (Garway-Heath 2007; Airaksinen et al. 1985; Airaksinen 
& Drance 1985).  The difference in strength of association as seen with the two 
structural imaging techniques confirms that each technique is measuring a different 
parameter of the RNFL and cannot be used interchangeably.  SLP provides a good and 
objective method for RNFL thickness evaluation (Chen et al. 2009) as it has shown a 
good correlation with histological measurements (Blumenthal et al. 2009; Cohen et al. 
2008).  RNFL parameters as measured with GDx VCC present a weak to moderate 
correlation with SAP VF indices in patients with glaucoma (Lopez-Pena et al. 2010) and 
may be a useful tool in distinguishing between normal and glaucomatous eyes (Chen et 
al. 2007; Chen et al. 2009; Reus & Lemij 2004b; Da Pozzo et al. 2006).   A recent study 
showed progression in RNFL retardance and function before loss of RNFL thickness 
and optic nerve axon counts in early experimental glaucoma in non-human primate 
models (Fortune et al. 2015).   
 
Clinically, it is important to determine the structure-function relationship with currently 
available techniques that measure structural and functional deficits as the combination 
of these two modalities is used for assessing the severity and progression of glaucoma.  
The results of this preliminary study suggest that FDF and GDx used in combination are 
best to detect early glaucomatous changes. 
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6  Study of Repeatability After 1 year for SAP, FDT, FDF and MDT 
 
6.1 Overview 
 
Purpose:  Preliminary study to determine which perimetry technique, SAP, FDT, FDF or 
MDT, is better able to detect repeatability after 1 year in early glaucoma. 
Methods:  38 subjects with early glaucoma had perimetry testing with SAP, FDT, FDF 
and MDT on two separate visits, approximately 1 year apart.  Pattern deviation 
probability maps were used to compare the threshold estimates.  Ordinal scores of 0, 2 
and 5 were assigned to PD values labeled as p>0.05, p<0.05 and p<0.02, respectively. 
Differences in ordinal scoring between the two visits with respect to each perimetry test 
were used to make comparisons amongst the techniques. 
Results:  FDF showed the greatest number of points with no change in ordinal scoring 
between visits, the majority of which were at p<0.02, i.e. had severe defect. With SAP, 
FDT and MDT, the majority of test locations which showed no progression were at the 
level of p>0.05, i.e. had earlier defect.  More improvement was detected than 
progression in nearly all stages of disease severity with all techniques.  
Conclusion: No one technique showed clear or better detection of disease progression.  
Further studies are required to determine which technique is best suited to monitor 
glaucomatous disease progression. 
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6.2 Introduction 
 
Progressive glaucomatous loss of retinal ganglion cells causes characteristic optic 
nerve, RNFL and visual field abnormalities (Epstein 1997; Johnson 2009; Nicolela et al. 
2001; Quigley 1993).  Management of glaucoma requires the detection and monitoring 
of progression (Haymes et al. 2005; Vesti et al. 2003) which relies on the detection of a 
deteriorating structural and/or functional measurement.  Early detection of glaucoma 
progression is just as important as early detection of the disease (Ansari et al. 2000) as 
progression of the disease can significantly impact visual function (Gupta & Weinreb 
1997) and quality of life (Gutierrez et al. 1997; Parrish et al. 1997; Sherwood et al. 1998; 
Jampel et al. 2002; Nelson et al. 2003; Hyman et al. 2005).  Automated perimeters 
along with standard thresholding algorithms (Anderson 1987) have improved our ability 
to quantify visual function and determine if visual function is deteriorating (Chauhan et 
al. 1990).   
 
For progression to be detected on any instrument, measurement “noise” must be 
distinguished from change due to glaucoma (Strouthidis et al. 2006).  Thus, detection of 
visual field progression depends on accuracy and reproducibility of threshold values at 
each visual field location tested (Artes et al. 2002).  
 
The purpose of a visual field examination in glaucoma is to detect defects and 
determine the specific pattern of visual field loss for diagnostic purposes, and monitor 
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patients for evidence of visual function defect progression (Chauhan et al. 1990; Spry et 
al. 2001; Spry & Johnson 2002).  The stimulus employed by SAP is non-selective for 
any particular ganglion cell subtype thus, SAP has shown to be a poor diagnostic test 
for patients with early glaucoma however, its performance improves (Spry et al. 2003) 
and variability increases (Harwerth et al. 2002; Weber & Rau 1992; Olsson et al. 1993; 
Wall et al. 1997; Chauhan et al. 1993; Henson et al. 1997) as sensitivity is reduced.  For 
this reason, it is an ideal measure for glaucoma progression.   
 
The key to managing a patient with glaucoma is to determine whether or not the 
patient’s visual status has progressed (Johnson 2009); changes in visual field have 
been used to determine progression of glaucoma (AGIS 1994; Anderson et al. 1998; 
Gordon & Kass 1999; Leske et al. 1999; CGS Group 2006; Musch et al. 1999).   
Detecting progression on visual fields is dependent on the instruments’ variability, the 
amount of change that is considered clinically significant and the number of follow-up 
examinations required to detect this change (Chauhan et al. 2008).  Small amounts of 
clinically significant visual field change can be detected with a sufficient number of 
examinations and follow-up time (Heijl et al. 2003; Vesti et al. 2003).  However, in 
everyday clinical practice, this may be difficult to achieve.  Thus, more accurate and 
reliable techniques are needed for glaucoma management.   
There is weak evidence supporting the notion that SWAP and FDT are more sensitive 
than SAP at detecting progression (Demirel & Johnson 2001; Haymes et al. 2005).    
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Several major glaucoma studies have looked at the progression of glaucoma but each 
uses different criteria to define it and the criteria used for one study may only be 
applicable to the study population of that particular study and not for the other.  These 
differences in methodology give rise to difficulties in comparing the results of these 
studies to each other in addition to the absence of a gold standard (Nouri-Mahdavi et al. 
1997; McNaught et al. 1996).   
 
The purpose of this research was to conduct a preliminary study to determine which 
perimetry technique(s) is better able to detect event-based progression. 
 
6.3 Methods 
 
The recruitment criterion was as described in Chapter 2 in section 2.2.  The study 
sample demographics are listed in Table 2.4.  The procedures are explained in section 
2.5. 
 
6.4 Analysis 
 
Because each visual field instrument uses a different scale to measure threshold 
values, pattern deviation probability plots were used to compare progression.  Only 
values of p>0.05, p<0.05 and p<0.02 were used as this was limited to the values that 
were calculated by the MDT.  Ordinal scores of 0, 2 and 5 were assigned to each of the 
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probability scores, respectively, an approach similar to that used to weight the 
Glaucoma Hemifield scores (Asman & Heijl 1992).  Scores from Visit A and Visit B were 
compared to detect progression.   
 
The difference between ordinal scores for each point was calculated to compare the 
average versus the difference of each point from Visit A to Visit B with respect the 
ordinal scores assigned.  Because only one follow-up data set was available for this 
study, a point-by-point analysis was performed and change was defined based on 
event-analysis. 
 
6.5 Results 
According to the frequency histogram (Figure 6.1), FDF showed the greatest number of 
points with no change and FDT showed the least number of points with no change. 
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Figure 6.1:  Frequency distribution of difference in ordinal score between Visit A and Visit B. 
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Figure 6.2:  Bland-Altman plots for comparing ordinal scores from Visit A to Visit B. 
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levels of stability over the one-year study period. MDT showed almost no change over 
the one-year study period, where as SAP was between the two. 
 
 
Table 6.1:  Total number of points showing the difference between Visit A and Visit B. The differences are 
categorized into 0, mild (±2), moderate (±3), and severe (±5) change. 
 no change 
(0) 
mild change 
(±2) 
moderate change 
(±3) 
severe change 
(±5) 
SAP 841 148 66 161 
FDT 827 106 49 234 
FDF 895 42 85 194 
MDT 870 284 11 51 
 
 
Table 6.2:  Showing the average of the two visits as a function of the differences defined in Table 6.1. 
change none mild moderate severe 
 (0, 0) (2, 0) (5, 0) (1, 2) (1, -2) (3.5, 3) (3.5, -3) (2.5, 5) (2.5, -5) 
SAP 636 18 187 82 66 32 34 86 75 
FDT 620 25 182 44 62 24 25 156 78 
FDF 211 13 671 24 18 47 38 144 50 
MDT 680 186 4 151 133 5 6 25 26 
(x, y) = (average, difference) as calculated from Visit A to Visit B. 
 
 
 
 
 
 
 
6.6 Discussion 
 
In glaucoma, quality of life is directly associated with the amount of the visual field 
damage (Gutierrez et al. 1997; Parrish et al. 1997; Sherwood et al. 1998; Jampel et al. 
2002; Nelson et al. 2003; Hyman et al. 2005) and is therefore important to detect and 
monitor progression of this disease.  Early detection of glaucomatous damage and its 
progression over time is one of the most important clinical challenges in glaucoma 
(Hood & Kardon 2007).  It is crucial to determine which techniques can accurately 
diagnose and detect glaucomatous progression throughout the course of the disease.  
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Thus, when comparing tests over time, it is crucial to distinguish between change due to 
progression of the disease and change due to variability of the algorithm.   
The majority of the test locations for all techniques showed no change in probability 
values from Visit A to Visit B.  This was expected as the subjects were well controlled 
with their glaucoma treatment.  When looking at the distribution with respect to severity 
of these test locations (Table 6.1), FDF showed the majority of its stable points 
classified as severe defect, whereas the majority of stable points from SAP, FDT and 
MDT were classified as near-normal.  Thus, FDF is better at detecting defect earlier 
than the other perimetry tests and it can repeatedly detect this defect as time 
progresses; however, there is also a notable number of points that show “improvement” 
with the FDF with locations originally detected as severely depressed which is attributed 
to the variability of the technique.  
FDT was the only technique that showed more points as progressing than improving in 
mild disease but more points as improving in severe disease.  This should be kept in 
mind when looking for signs of disease progression with these techniques. 
Overall, more improvement was detected than progression in nearly all stages of 
disease severity with all techniques except for mild changes with the FDT.  
 
The results of this preliminary study suggest that FDF detects more defect than any 
other technique.  What the study does not tell us is the technique that most accurately 
and precisely illustrates disease progression. We can conclude that FDF determines the 
most abnormality at baseline in patients with early glaucoma, and that MDT shows the 
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least abnormality and the greatest variability in early glaucoma defect. No one technique 
showed clear detection of disease progression.  Factors such as too few ordinal scores, 
only one follow-up visit and only one year duration contribute to the limitations of this 
study. Further studies  with longer follow-up periods and more frequent testing are 
required to determine whether either of these techniques are suitable for monitoring 
disease and determining progression.  Detecting progression on visual fields is 
dependent on the instruments’ variability, the amount of change that is considered 
clinically significant and the number of follow-up examinations required to detect this 
change (Chauhan et al. 2008).  Theoretically, small amounts of clinically significant 
visual field change can be detected with a sufficient number of examinations and follow-
up time (Heijl et al. 2003; Vesti et al. 2003).  However, in everyday clinical practice, this 
may be difficult to achieve.   
 
Progressive optic neuropathy is the hallmark of glaucoma (Fechtner & Lama 1999).  
Detection of visual field progression depends on accuracy and reproducibility of 
threshold values at each visual field location tested (Artes et al. 2002).  Thus, accurately 
detecting glaucomatous change will be an asset to the diagnosis and management of 
this disease. 
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7 Discussion 
 
One of the most important clinical challenges in glaucoma is the early detection of 
glaucomatous damage and its progression (Hood & Kardon 2007).  It is crucial to 
determine which techniques can accurately diagnose and detect glaucomatous 
progression throughout the course of the disease.  The aim of this thesis was just that:  
to determine which perimetry technique, SAP, FDT, FDF or MDT, is better able to detect 
early changes in glaucoma and whether or not visual function as measured by these 
techniques corresponds to measures of ONH and RNFL structure as determined by 
HRT, OCT and GDx.   
 
The development of new perimetry techniques are aimed at selectively stimulating 
various properties of the retina which are lost in the early stages of glaucoma, before 
significant, irreversible impairment of vision.  Repeatability of SAP, FDT, FDF and MDT 
were compared in patients with early stage glaucoma and controls.  Test-retest 
variability was determined by comparing visual field indices and threshold estimates.  
Each patient was examined on two separate occasions with each of the four techniques.  
 
Overall, both SAP and MDT showed similar trend in variability:  it increased as 
sensitivity decreased.  This is in agreement with previously published studies (Henson 
et al. 1997; Russell et al. 2012).  FDT and FDF also showed a similar trend in variability:  
both had uniform variability throughout the dynamic range, with FDF having a narrower 
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95% confidence interval throughout.  These findings were also in agreement with 
previously published studies ( Heidelberg Edge Perimeter 2010; Artes, Hutchison, et al. 
2005). 
 
Global indices were used to compare the overall severity of each visual field test.  MDT 
was not included in this analysis as it does not calculate MD or PSD.  Overall, FDF 
showed the greatest amount of defect, and SAP showed the least.  No significant 
difference was found in PSD of FDT and FDF, however, they show slightly greater 
localized reduction of sensitivity when compared to SAP.  Frequency of differences 
between visits showed FDT as having the highest fraction of 0 dB difference.  This is 
attributed to the fact that FDT has a smaller number of final threshold estimates 
compared to the other techniques (i.e. 15 vs 29 or 39).  These findings suggest that 
SAP may not be suitable to detect or monitor functional damage caused by glaucoma in 
the early stages as readily as FDT and/or FDF. 
 
The ability to detect change after one year was measured by comparing the pattern 
deviation probability maps from each of these instruments. Both FDF and FDT showed 
the same number of points with little or no change.  SAP and MDT showed greater 
stability than either of the aforementioned techniques with MDT having almost no points 
with significant change.  These results suggest that both FDT and FDF are equally 
capable of detecting changes in the early stages of the disease and MDT is unlikely to 
 121 
provide any advantage in clinical performance when compared to SAP, FDT and FDF. 
FDF showed deeper defect at baseline.  
 
Agreement between HRT and the perimetry tests were analyzed using both global and 
sectoral comparisons.  The maps created by Garway-Heath (2000) were used to group 
the functional test locations to the six ONH sectors.  Visual field sectors were then 
classified into WNL and ONL and compared to the Moorfields Regression Analysis 
classification of the HRT.   
 
With all perimetry tests, the greatest agreement was seen in eyes that were classified 
as glaucomatous based on this study inclusion/exclusion criterion.  In both the 
glaucoma and control group, global classifications of SAP, FDT and MDT showed 
similar agreement with HRT however, FDF showed the greatest agreement when HRT 
classified the ONH as ONL and least agreement when the ONH was classified as WNL.  
Thus, calculations of sensitivity and specificity showed FDT to have a significantly 
higher sensitivity and lower specificity than the remaining three perimetry tests which 
had their values in roughly the same range.  Because no one perimetry test has ideal 
sensitivity and specificity, it is recommended that a combination of FDF with either SAP 
or FDT be used as the functional component in the diagnosis and management of 
patients with glaucoma. 
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The structure-function analysis was taken a step further by adding data from OCT and 
GDx VCC.  Again, the data from both OCT and GDx VCC was recalculated to fit the 6-
sector ONH map from the HRT.  Initially, RNFL thickness comparisons were made 
between the two imaging techniques using regression analysis.  The four perimetry 
tests were then compared to the OCT and GDx RNFL values. 
 
Both imaging techniques showed the classic double-hump pattern with the normal 
anatomy of the RNFL.  The measurements of the OCT were approximately 1.5 times 
thicker than that of the GDx in all 6 sectors; this was seen in previously published 
studies comparing these two instruments (Kim et al. 2011; Leung et al. 2005).  The 
standard deviations from each sector increased in the same sectoral order for both 
instruments; inferionasal, superiotemporal, superionasal, inferiotemporal, nasal and 
temporal.  Although both instruments have comparable ability to detect early glaucoma 
damage, the results are not interchangeable and progressive change should be 
monitored with only one instrument. 
 
The strongest structure-function correlations for OCT were seen with SAP, FDT and 
MDT, and GDx with FDF.  RNFL thickness as measured by the GDx is based on the 
birefringence of both RNFL axons and organelles from supporting structures; changes 
such as partial loss of supporting cell organelles or shrinkage of ganglion cells may alter 
the total birefringence of the RNFL before irreversible loss of axons occurs (Weber et al. 
1998; Shou et al. 2003).  Hence, changes in birefringence would be noted earlier than 
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changes of axonal number.  With this concept and the results from test-retest analysis, 
it is not surprising that FDF showed stronger association with GDx whereas SAP, FDT 
and MDT were more strongly associated with OCT.   
 
The results from this thesis suggest that both FDF and GDx be used in combination to 
detect changes in the early stages of glaucoma.  SAP and FDT are likely better at 
monitoring change as the disease advances. 
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8 Limitations of the Study 
 
Despite the fact that this study was carried through as precisely as possible, there were 
several limitations, most of which have to do with the data analysis.  First of all, each 
instrument, whether functional or structural, has a normal database that is unique to it.  
This affects the indices and the probability calculations.  For the functional tests, each 
technique uses a different dB scale, which makes direct comparisons of these 
techniques very difficult.  The structural instruments each utilize a different property of 
light to measure thickness of the retina making direct comparisons of these data very 
difficult as well.  
Second was the difference in test location co-ordinates amongst the functional and 
structural instruments of which data points had to be recalculated for any comparison to 
be made.  Not all sectors overlap to the same number of data points and some sectors 
have a greater density of RGCs than others.   
The data collected was only limited to patients with early glaucoma and controls thus, in 
areas where sectors of perimetry tests and/or structural tests were analyzed, there were 
far more sectors that were classified as WNL in comparison to ONL.  
The change after one year data had a small sample size and only one follow-up visit. 
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